Cardiovascular diseases (excluding rheumatic etc)

FG_CVD

cardiovascular disease: A disease involving the cardiovascular system.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints FG_HYPERTENSION I9_ISCHHEART I9_PULMEMB FG_OTHHEART FG_CEREBVASC FG_DOAAC FG_DISVEINLYMPH FG_OTH	254754
6. Filter based on genotype QC (FinnGen only)	254754

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	FG_CVD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	FG_HYPERTENSION\|I9_ISCHHEART\|I9_PULMEMB\|FG_OTHHEART\|FG_CEREBVASC\|FG_DOAAC\|FG_DISVEINLYMPH\|FG_OTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiovascular diseases (excluding rheumatic etc) based on the number of shared cases.

Similar with more cases:

Cardiovascular diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	254754	123693	131061
Unadjusted period prevalence (%)	50.20	42.16	57.78
Median age at first event (years)	53.97	51.64	56.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9146: Matched controls
75896

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C07AB07

ATC

bisoprolol; oral

6.1

323.0

2463

4320

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

11.9

323.0

2127

1885

XF404

NOMESCO Finland

Ambulatory ECG

10.4

323.0

960

850

I10

ICD-10 Finland

Essential (primary) hypertension

14.7

323.0

2307

1698

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

323.0

3130

9311

TFP34

NOMESCO Finland

Electrophysiological investigation

92.4

323.0

525

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

321.1

323.0

480

XF400

NOMESCO Finland

ECG with 12 standard connections

5.5

323.0

1401

2427

C09AA02

ATC

enalapril; systemic

11.5

323.0

796

626

B01AA03

ATC

warfarin; systemic

58.4

323.0

886

139

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.3

323.0

1057

1543

I48

ICD-10 Finland

Atrial fibrillation and flutter

244.3

323.0

393

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

18.7

323.0

643

305

I47.1

ICD-10 Finland

Supraventricular tachycardia

107.4

323.0

1024

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

96.3

323.0

389

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.7

323.0

1036

1244

C09AA05

ATC

ramipril; oral

13.4

323.0

743

498

C03CA01

ATC

furosemide; systemic

12.6

323.0

855

616

C08CA01

ATC

amlodipine; oral

14.3

323.0

1226

810

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

12.0

323.0

1474

1196

C09CA01

ATC

losartan; oral

10.1

323.0

793

704

B01AB05

ATC

enoxaparin; parenteral

3.8

323.0

2086

5502

205

Kela drug reimbursment

Chronic hypertension

+∞

323.0

733

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

22.3

323.0

566

224

XF402

NOMESCO Finland

ECG with work load test

11.9

301.9

601

446

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

10.2

293.2

630

545

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

8.4

274.4

660

696

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

29.8

266.4

383

111

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

399.3

262.2

281

C07AB02

ATC

metoprolol; systemic

5.5

256.9

839

1358

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

458.5

252.2

269

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

49.9

251.8

325

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

31.3

250.6

356

C10AA05

ATC

atorvastatin; oral

6.3

239.1

697

974

AA1AD

NOMESCO Finland

CT of head and brain

3.4

229.9

1268

3389

I45.6

ICD-10 Finland

Pre-excitation syndrome

300.1

228.7

248

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

74.1

227.9

277

201

Kela drug reimbursment

Chronic cardiac insufficiency

42.4

227.2

302

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.4

226.4

587

693

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

510.0

225.7

240

B01AF01

ATC

rivaroxaban; oral

24.4

224.1

340

120

A02BC02

ATC

pantoprazole; systemic

2.1

224.0

4194

22013

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

222.0

1647

5413

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

86.7

221.5

264

I25.1

ICD-10 Finland

Atherosclerotic heart disease

334.6

219.6

237

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

228.8

219.1

241

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.7

215.1

1082

2676

TPH07

NOMESCO Finland

Cathetrisation of artery

5.4

209.4

697

1145

I34.1

ICD-10 Finland

Mitral (valve) prolapse

91.2

207.6

246

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

205.5

1423

4451

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

46.0

205.5

269

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

25.9

200.6

299

N02AX02

ATC

tramadol; systemic, rectal

2.3

193.2

2304

9752

R4110

NOMESCO Finland

Physiotherapy

2.5

188.6

1854

7103

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

185.5

2175

9103

C09CA06

ATC

candesartan; oral

3.2

185.3

1110

3123

I50.9

ICD-10 Finland

Heart failure, unspecified

821.4

184.5

194

127

Kela drug reimbursment

Transplant complication

23.6

184.5

282

102

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

77.9

182.2

220

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

799.8

179.6

189

Z94.0

ICD-10 Finland

Kidney transplant status

46.3

179.1

234

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

178.8

1350

4432

103

Kela drug reimbursment

Diabetes, insulin-treated

3.2

178.3

1064

2981

207

Kela drug reimbursment

Chronic arrhythmias

103.9

178.0

208

C08CA13

ATC

lercanidipine; oral

20.0

177.0

285

122

WX892

NOMESCO Finland

Monitored bed care

4.7

175.7

661

1238

N02BE01

ATC

paracetamol; systemic, rectal

2.0

174.9

6856

45650

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.2

174.7

1048

2945

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

31.0

173.7

247

L04AA06

ATC

mycophenolic acid; systemic

17.8

172.5

289

139

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

9.4

172.4

385

353

TK800

NOMESCO Finland

Hemodialysis

33.9

171.7

239

R06.0

ICD-10 Finland

Dyspnoea

2.5

168.9

1612

6039

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

93.3

167.5

198

B01AC04

ATC

clopidogrel; oral

63.5

162.8

202

B01AF02

ATC

apixaban; oral

57.6

162.1

204

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.7

158.4

1220

4032

M79.6

ICD-10 Finland

Pain in limb

2.0

158.2

2678

12989

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

36.9

156.0

213

I47.2

ICD-10 Finland

Ventricular tachycardia

82.9

155.3

186

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

16.1

154.4

268

142

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

7.8

154.1

384

423

I88.0

ICD-10 Finland

Nonspecific mesenteric lymphadenitis

460.5

153.6

164

C10AA01

ATC

simvastatin; oral

6.1

151.5

452

644

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

149.3

1412

5231

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

147.0

1112

3621

AQ1

Conventional electrophysiological examination

129.1

146.8

168

TFP20

NOMESCO Finland

Cardiodefibrillation

327.4

144.4

156

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.9

143.7

663

1502

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

30.9

143.5

204

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

142.7

1524

5996

FM2CE

NOMESCO Finland

9.8

142.3

310

271

C03DA01

ATC

spironolactone; oral

5.8

142.0

436

644

N18.8

ICD-10 Finland

Other chronic renal failure

32.3

140.8

198

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

1262.3

140.7

147

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

420.3

140.1

150

WX402

NOMESCO Finland

General anaesthesia

2.3

139.5

1515

6003

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

5.5

139.3

452

714

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.9

138.8

501

893

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

9.3

138.5

310

285

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

68.1

137.6

169

WX872

NOMESCO Finland

Intensive care

9.9

137.0

296

255

R00.2

ICD-10 Finland

Palpitations

3.2

135.5

819

2293

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

57.4

135.1

170

A11CC03

ATC

alfacalcidol; systemic

14.2

134.3

245

147

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

84.5

134.0

160

N03AX16

ATC

pregabalin; oral

2.5

133.7

1237

4507

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

131.2

1221

4459

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

23.5

131.0

200

Q23.11

ICD-10 Finland

Bicuspid aortic valve

37.4

130.1

177

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

388.9

129.5

139

AN2

Balloon angioplasty, including several vessels

+∞

129.2

133

N02AA05

ATC

oxycodone; systemic

4.5

128.8

496

945

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

128.5

1684

7250

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

69.8

128.3

157

ZX120

NOMESCO Finland

Intravenous

3.3

128.3

714

1880

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

89.8

125.7

149

R50.9

ICD-10 Finland

Fever, unspecified

2.2

124.3

1433

5813

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

277.9

122.2

133

B03XA02

ATC

darbepoetin alfa; parenteral

47.3

120.8

157

Z49.1

ICD-10 Finland

Extracorporeal dialysis

60.3

120.1

150

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

119.2

3533

20280

PHD99

NOMESCO Finland

Resection of other vein

9.9

118.6

256

220

I42.0

ICD-10 Finland

Dilated cardiomyopathy

528.9

118.5

126

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

118.3

1585

6860

XF600

NOMESCO Finland

Bloodpressure measurement

3.5

117.6

607

1505

137

Kela drug reimbursment

Uraemia requiring dialysis

84.3

117.2

140

R51.80

ICD-10 Finland

Headache

2.0

115.3

1814

8374

SPAT1262

SPAT

Handing over of treatment supplies

2.5

115.0

1018

3601

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

113.7

976

3393

A10AE04

ATC

insulin glargine; parenteral

3.2

113.6

672

1844

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

8.0

113.2

277

296

C08CA02

ATC

felodipine; oral

16.0

112.5

195

103

A12AA04

ATC

calcium carbonate; oral

36.1

112.4

154

WX002

NOMESCO Finland

Sedation and analgesia

2.4

111.8

1061

3891

ZXA00

NOMESCO Finland

Right side

2.3

111.8

1159

4447

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

10.9

111.0

228

178

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

49.8

110.4

142

XX3BT

NOMESCO Finland

Other labeling with X-ray guidance

51.3

109.3

140

K85

ICPC

Elevated blood pressure

4.3

108.7

445

899

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

108.2

485

1066

H3603, E103

ICD-10 Finland

9.0

108.0

246

233

TFP35

NOMESCO Finland

Electroanatomical mapping

39.4

107.9

145

SPAT1097

SPAT

Recording of ECG

3.1

107.8

658

1846

C01AA05

ATC

digoxin; systemic

50.2

106.6

137

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.5

106.5

417

806

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

166.7

106.2

119

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

33.5

105.6

147

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

24.4

105.4

159

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

58.6

105.3

132

C07AA05

ATC

propranolol; systemic

1.9

105.1

1844

8832

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.7

105.1

500

1157

J01AA02

ATC

doxycycline; systemic

1.6

104.8

4759

30392

C07AG02

ATC

carvedilol; oral

39.3

104.1

140

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

103.7

3153

18022

WZC30

NOMESCO Finland

Teaching

2.8

103.5

752

2365

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

103.5

580

1529

H02AB06

ATC

prednisolone; systemic

1.7

103.2

2951

16565

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

102.9

106

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.6

102.4

850

2893

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

74.5

102.4

124

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

231.8

100.1

110

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.8

99.1

246

269

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

+∞

99.0

102

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

11.0

97.6

199

153

CKC12

NOMESCO Finland

Photocoagulation of retina

5.4

97.4

315

494

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.7

97.0

730

2341

XFE00

NOMESCO Finland

Epicardial ultrasonography

13.5

96.9

180

113

E66.8

ICD-10 Finland

Other obesity

3.3

96.4

538

1412

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

223.0

96.3

106

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

13.3

95.4

178

113

A10BA02

ATC

metformin; oral

2.5

95.3

830

2896

V03AE01

ATC

polystyrene sulfonate; oral

115.5

95.3

110

I50.1

ICD-10 Finland

Left ventricular failure

+∞

95.1

XF602

NOMESCO Finland

Bloodpressure monitoring

22.1

94.8

147

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

93.9

647

1963

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

93.3

1939

9792

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

93.2

2807

15882

J01FF01

ATC

clindamycin; systemic

1.8

92.6

1862

9297

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

92.2

794

2751

C10AA07

ATC

rosuvastatin; oral

4.2

91.8

385

795

J01DB01

ATC

cefalexin; oral

1.7

91.8

7131

51455

C08CA05

ATC

nifedipine; systemic

4.7

91.7

338

614

N03AX12

ATC

gabapentin; oral

2.5

91.3

818

2894

B05DA

ATC

Isotonic solutions

71.8

91.2

111

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.4

90.3

360

708

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

45.1

90.2

118

J01MA12

ATC

levofloxacin; systemic

2.4

90.0

856

3125

N05BA04

ATC

oxazepam; oral

1.8

90.0

1892

9577

G47.3

ICD-10 Finland

Sleep apnoea

2.5

89.2

800

2833

K80

ICPC

Cardiac arrhythmia NOS

3.6

88.7

440

1052

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.7

88.3

672

2166

R42

ICD-10 Finland

Dizziness and giddiness

2.1

88.0

1162

4944

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

87.1

1574

7554

C02AC05

ATC

moxonidine; oral

86.4

86.7

103

Z49.2

ICD-10 Finland

Other dialysis

86.4

86.7

103

C09CA03

ATC

valsartan; oral

11.0

86.5

176

135

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.8

86.0

612

1892

I49.3

ICD-10 Finland

Ventricular premature depolarization

4.0

85.9

378

815

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

85.8

685

2271

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

94.2

85.8

101

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

85.3

690

2304

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.1

85.1

515

1430

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

4.6

85.0

319

590

XCK10

NOMESCO Finland

Photography of fundus of eye

3.0

84.9

536

1534

WX882

NOMESCO Finland

High dependency care

4.3

84.6

339

670

C09DA01

ATC

losartan and diuretics; oral

13.8

84.0

154

N18.0

ICD-10 Finland

End-stage renal disease

66.5

83.9

103

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.1

83.7

519

1467

P01AB01

ATC

metronidazole; oral, rectal

1.6

82.6

2765

15978

T90

ICPC

Diabetes non-insulin dependent

3.2

82.5

484

1315

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

12.2

82.5

160

111

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

41.2

81.3

108

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

80.9

1422

6739

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.2

80.1

269

441

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.2

80.0

456

1213

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

79.6

413

1023

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

79.6

659

2228

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

+∞

79.5

TFP41

NOMESCO Finland

Ablation treatment of manifest ancillary pathway

+∞

79.5

ZXA05

NOMESCO Finland

Left side

2.1

79.4

1006

4193

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

97.4

79.3

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

79.0

729

2611

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

11.7

78.5

155

112

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

96.4

78.4

WX110

NOMESCO Finland

Local anesthesy

1.6

78.1

6510

46492

I45.8

ICD-10 Finland

Other specified conduction disorders

147.4

77.9

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

77.6

1163

5188

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

77.6

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

+∞

77.6

B05DB

ATC

Hypertonic solutions

107.7

77.6

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

10.2

77.5

164

136

UJF32

NOMESCO Finland

Coloscopy

2.1

77.2

1021

4330

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.2

77.0

223

305

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

23.4

76.9

117

L04AD01

ATC

ciclosporin; systemic

6.0

76.7

227

319

N05AH04

ATC

quetiapine; oral

1.7

76.7

1767

9144

N17.9

ICD-10 Finland

Acute renal failure, unspecified

13.1

76.3

143

N05CF01

ATC

zopiclone; oral

1.9

76.0

1399

6724

S18

ICPC

Laceration/cut

1.6

75.4

2417

13736

C09BA02

ATC

enalapril and diuretics; systemic

23.1

74.1

113

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

49.8

74.0

N06AX11

ATC

mirtazapine; oral

1.7

74.0

2135

11779

PHD76

NOMESCO Finland

Resection of long saphenous vein

28.1

73.9

107

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

73.9

2560

14829

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

73.9

1390

6726

ZXA10

NOMESCO Finland

Bilateral

2.0

73.8

1059

4634

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

81.9

73.7

R60.0

ICD-10 Finland

Localized oedema

3.0

73.7

467

1338

R55

ICD-10 Finland

Syncope and collapse

2.6

73.2

610

2065

H43.1

ICD-10 Finland

Vitreous haemorrhage

9.2

73.2

163

149

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

73.0

1237

5767

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.4

72.9

381

949

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.2

72.6

416

1110

I44.1

ICD-10 Finland

Atrioventricular block, second degree

324.7

72.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

634.9

71.9

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

71.8

Congenital heart failure surgery

25.4

71.4

106

J01MA02

ATC

ciprofloxacin; systemic

1.7

70.7

1993

10906

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

113.0

70.2

A10AA02

ATC

3.5

69.7

357

875

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

311.9

69.4

A10AA01

ATC

3.5

69.2

357

880

A02BC01

ATC

omeprazole; systemic

1.8

69.1

1536

7830

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

60.1

69.1

T89

ICPC

Diabetes insulin dependent

2.7

68.3

522

1681

G44.2

ICD-10 Finland

Tension-type headache

1.9

68.2

1236

5889

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.5

68.0

190

248

I95.1

ICD-10 Finland

Orthostatic hypotension

20.1

67.9

108

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

+∞

67.9

I35.0

ICD-10 Finland

Aortic (valve) stenosis

+∞

67.9

E66.00

ICD-10 Finland

Metabolic syndrome

4.3

67.4

272

541

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

94.5

67.2

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.4

67.2

350

869

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

67.1

2275

13042

M03BX02

ATC

tizanidine; oral

1.5

66.9

4212

27800

Catheterization and pressure measurement of the left side of the heart

45.5

66.8

B01AB10

ATC

tinzaparin; parenteral

3.6

66.6

321

749

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

9.0

66.3

150

141

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

66.2

281

586

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

27.7

66.2

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

+∞

65.9

K86

ICPC

Hypertension uncomplicated

8.5

65.4

152

150

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

65.2

4487

30101

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

36.8

64.9

H02AB04

ATC

methylprednisolone; systemic

2.2

64.8

725

2846

A02BC05

ATC

esomeprazole; systemic

1.6

64.7

2000

11179

Z49.0

ICD-10 Finland

Preparatory care for dialysis

66.2

64.4

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.2

64.4

756

3032

C01BC04

ATC

flecainide; systemic

23.9

64.3

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.4

64.0

335

835

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.8

63.8

293

656

N06AB04

ATC

citalopram; systemic

1.8

63.6

1403

7113

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

63.6

2703

16327

K94

ICPC

Phlebitis/thrombophlebitis

17.4

63.5

106

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

+∞

63.0

R03AC02

ATC

salbutamol; inhalant

1.5

62.9

4336

29013

A10AE05

ATC

insulin detemir; parenteral

2.7

62.8

483

1560

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

62.8

525

1780

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

101.8

62.6

H02AB09

ATC

hydrocortisone; systemic

3.8

62.4

286

639

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

62.1

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

62.0

1417

7260

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

146.3

62.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

62.0

479

1552

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

118.7

61.8

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

278.1

61.7

D68.8

ICD-10 Finland

Other specified coagulation defects

6.8

61.4

166

207

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.3

61.3

200

318

C09CA07

ATC

telmisartan; oral

9.3

61.1

135

122

TFP42

NOMESCO Finland

Ablation treatment of hidden ancillary pathway

+∞

61.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

61.0

1548

8176

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

60.8

367

1013

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

3.6

60.7

296

697

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

60.4

408

1216

R4190

NOMESCO Finland

Nutritional therapy

2.8

60.2

415

1252

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

7.0

60.0

158

190

L04AX01

ATC

azathioprine; systemic

2.7

59.8

443

1397

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.7

59.4

219

398

A46

ICD-10 Finland

Erysipelas

2.7

59.4

448

1429

V03AE02

ATC

sevelamer; oral

183.8

59.4

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

8.0

59.3

143

150

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

140.0

59.2

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.5

59.1

303

743

H04AA01

ATC

glucagon; nasal, parenteral

2.5

59.1

498

1693

J01FA06

ATC

roxithromycin; oral

1.5

59.1

2475

14843

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

14.7

59.0

105

B01AB04

ATC

dalteparin; parenteral

4.1

59.0

246

505

K93

ICPC

Pulmonary embolism

265.4

58.8

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

4.4

58.7

226

430

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

181.0

58.5

Q25.1

ICD-10 Finland

Coarctation of aorta

17.9

58.1

B03XA01

ATC

erythropoietin; parenteral

44.8

57.5

Z71.8

ICD-10 Finland

Other specified counselling

1.5

57.5

2419

14503

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

57.2

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

57.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

57.1

4220

28403

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

6.6

57.0

156

198

R11

ICD-10 Finland

Nausea and vomiting

2.0

57.0

806

3490

K04

ICPC

Palpitations/awareness of heart

2.7

57.0

416

1302

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

57.0

2879

17960

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

8.8

56.7

129

123

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

5.2

56.5

189

309

N05BA01

ATC

diazepam; systemic, rectal

2.1

56.5

711

2933

AN1

Coronary angiography

500.0

56.4

Q21.10

ICD-10 Finland

Persistent ostium secundum

7.0

56.4

148

177

I51.4

ICD-10 Finland

Myocarditis, unspecified

9.0

56.4

127

119

SPAT1255

SPAT

Intravenous administration of medicine

2.9

56.3

372

1094

TK820

NOMESCO Finland

Peritoneal dialysis

58.6

56.2

I15.8

ICD-10 Finland

Other secondary hypertension

91.9

56.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

55.9

473

1613

I20.99

ICD-10 Finland

Angina pectoris, unspecified

172.6

55.6

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

55.6

1522

8188

N06AX16

ATC

venlafaxine; oral

1.7

55.6

1250

6354

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

55.4

1207

6074

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

55.4

1739

9701

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

55.3

I44.0

ICD-10 Finland

Atrioventricular block, first degree

107.0

55.3

WX704

NOMESCO Finland

Intubation

2.4

55.2

497

1750

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

55.2

5408

38277

A41.9

ICD-10 Finland

Sepsis, unspecified

4.9

55.1

194

336

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

55.1

942

4376

M54.5

ICD-10 Finland

Low back pain

1.5

54.9

2495

15183

K84

ICPC

Heart disease other

23.2

54.6

C10AX09

ATC

ezetimibe; oral

8.3

54.5

128

129

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

54.4

551

2060

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

247.9

54.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

53.9

371

1120

L04AA01

ATC

[U] ciclosporin; systemic

8.1

53.7

128

132

N06AX21

ATC

duloxetine; oral

2.0

53.6

717

3034

JN4BD

NOMESCO Finland

Extensive body CT

3.1

53.2

315

860

196

Kela drug reimbursment

Paricalcitol and cinacalcet

243.5

53.1

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

7.2

52.9

136

158

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

52.8

1137

5696

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.4

52.8

169

263

I50.0

ICD-10 Finland

Congestive heart failure

466.3

52.6

R07.3

ICD-10 Finland

Other chest pain

2.4

52.2

489

1758

C09DA06

ATC

candesartan and diuretics; oral

10.4

52.1

108

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

51.8

409

1340

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

+∞

51.4

J01MA14

ATC

moxifloxacin; systemic

2.6

51.3

399

1296

K78

ICPC

Atrial fibrillation/flutter

32.9

51.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

9.1

51.2

114

105

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.7

51.0

126

138

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

46.0

50.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.8

50.7

154

225

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.1

50.7

171

283

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

449.4

50.7

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

449.4

50.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.6

50.6

391

1264

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

27.7

50.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

6.5

50.4

139

179

E11

ICD-10 Finland

Type 2 diabetes mellitus

3.6

50.2

242

565

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

49.7

543

2100

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

49.7

791

3575

SPAT1263

SPAT

Sampling

1.4

49.5

3833

25765

C01BD01

ATC

amiodarone; systemic

+∞

49.4

L17

ICPC

Foot/toe symptom/complaint

1.6

49.4

1621

9109

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.9

49.3

131

160

Electrophysiological Special Examination

226.1

49.3

A10BK03

ATC

empagliflozin; oral

4.9

49.1

170

290

SPAT1153

SPAT

Removal of sutures

1.6

48.9

1573

8797

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

48.7

525

2020

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

22.9

48.7

I45.9

ICD-10 Finland

Conduction disorder, unspecified

80.7

48.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

48.6

685

2953

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

48.5

4480

31026

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

48.5

1661

9431

B01AC24

ATC

ticagrelor; oral

+∞

48.5

TK810

NOMESCO Finland

Hemofiltration

41.1

48.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

48.2

3753

25210

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

9.3

48.1

106

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

47.8

491

1845

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.0

47.8

202

421

G04BE03

ATC

sildenafil; oral

27.5

47.7

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

10.0

47.7

101

R53

ICD-10 Finland

Malaise and fatigue

1.6

47.5

1571

8834

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

47.4

1417

7769

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.3

47.4

188

369

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

47.2

324

977

N03AX09

ATC

lamotrigine; oral

2.1

47.0

605

2515

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

47.0

6657

49554

H3601, E103

ICD-10 Finland

4.6

47.0

174

319

602

Kela drug reimbursment

Children's severe malnutrition

5.9

46.9

139

197

I95.9

ICD-10 Finland

Hypotension, unspecified

16.5

46.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.4

46.7

243

604

AR2

Catheter ablation of arrhythmia, target: extra pathway (WPW, AVRT, PJRT)

+∞

46.5

K04.0

ICD-10 Finland

Pulpitis

1.7

46.5

1086

5562

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

33.4

46.4

XF622

NOMESCO Finland

Measurement of minute volume of heart

49.3

46.2

C07AB03

ATC

atenolol; systemic

7.4

46.1

116

131

M25.5

ICD-10 Finland

Pain in joint

1.5

45.9

1857

10939

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

45.7

694

3078

V03AE03

ATC

lanthanum carbonate; oral

+∞

45.6

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

45.6

R4120

NOMESCO Finland

Occupational therapy

2.4

45.5

409

1438

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.0

45.5

653

2835

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

11.0

45.3

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

45.2

296

866

C08DA01

ATC

verapamil; systemic

5.1

45.1

152

252

Z99.2

ICD-10 Finland

Dependence on renal dialysis

65.6

45.0

N05CF02

ATC

zolpidem; oral

1.7

44.6

1014

5143

GD1AD

NOMESCO Finland

Thorax CT examination

4.9

44.6

156

269

A28

ICPC

Limited function/disability NOS

2.7

44.5

331

1048

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.7

44.3

119

148

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

44.3

808

3826

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

51.9

44.2

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

9.1

44.2

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

57.5

44.1

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

20.6

44.0

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

390.6

43.9

J01DA01

ATC

[U] cefalexin; systemic

1.4

43.8

4545

31866

C07AA07

ATC

sotalol; systemic

40.3

43.8

M01AH05

ATC

etoricoxib; oral

1.4

43.8

3235

21418

I26

ICD-10 Finland

Pulmonary embolism

24.7

43.7

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.7

43.7

157

279

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

43.7

841

4051

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

43.6

Catheterization and pressure measurement of the right side of the heart

43.2

43.6

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

43.5

280

809

GD1LA

NOMESCO Finland

25.5

43.4

K06.18

ICD-10 Finland

Another gingival hyperplasia

18.0

43.3

L28

ICPC

Limited function/disability (L)

2.1

42.7

512

2062

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

10.2

42.7

XF405

NOMESCO Finland

Symptom ECG

10.9

42.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.1

42.6

101

104

Z94.1

ICD-10 Finland

Heart transplant status

83.4

42.2

K90

ICPC

Stroke/cerebrovascular accident

38.9

42.0

A02BC03

ATC

lansoprazole; oral

1.7

42.0

1027

5319

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.1

41.9

175

361

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

41.8

430

1617

T82

ICPC

Obesity

2.5

41.8

350

1186

R02

ICPC

Shortness of breath/dyspnoea

1.8

41.7

754

3556

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

41.7

2229

13872

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

41.7

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.6

41.6

200

467

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

34.0

41.6

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.8

41.5

286

864

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

41.4

875

4338

H36.01

ICD-10 Finland

Diabetic maculopathy

5.9

41.3

123

176

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

20.1

41.2

H03AA01

ATC

levothyroxine sodium; systemic

1.6

41.1

1281

7074

M01AB05

ATC

diclofenac; systemic, rectal

1.4

41.1

3991

27564

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

365.3

41.0

5AB14

NOMESCO Finland

31.7

40.9

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

10.5

40.9

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

+∞

40.7

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

40.7

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

+∞

40.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

40.7

265

773

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

40.5

928

4715

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

40.3

367

1298

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

40.3

637

2863

C03AA03

ATC

hydrochlorothiazide; oral

12.8

40.1

Q21.30

ICD-10 Finland

Tetralogy of Fallot

31.2

40.1

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

26.9

40.0

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

6.0

40.0

117

164

TAB00

NOMESCO Finland

Lumbar puncture

2.3

39.9

384

1399

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

39.8

244

683

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

183.4

39.7

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

39.6

348

1208

K99

ICPC

Cardiovascular disease other

15.2

39.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

39.5

310

1012

XCK00

NOMESCO Finland

Perimetry

2.9

39.4

257

750

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.2

39.2

100

116

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

39.0

1475

8518

N06AB06

ATC

sertraline; oral

1.6

39.0

1051

5583

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

38.9

924

4738

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

+∞

38.8

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

+∞

38.8

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

+∞

38.8

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.8

38.6

742

3566

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

122.3

38.6

ZX199

NOMESCO Finland

Other rote

17.2

38.6

A10AE06

ATC

insulin degludec; parenteral

2.6

38.6

301

980

SPAT1260

SPAT

Consultation of another employee

1.6

38.5

1300

7311

A10BK01

ATC

dapagliflozin; oral

4.9

38.4

132

224

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.7

38.4

180

412

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

13.3

38.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

37.9

1522

8901

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

3.1

37.8

221

599

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

50.0

37.8

XX3DW

NOMESCO Finland

Time consuming IT work

2.4

37.7

334

1167

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.6

37.5

179

416

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.1

37.4

219

595

J01FA09

ATC

clarithromycin; systemic

1.4

37.1

2179

13748

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

37.0

326

1134

N19

ICD-10 Finland

Unspecified kidney failure

11.3

36.9

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

36.8

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.7

36.7

272

859

Z00.0

ICD-10 Finland

General medical examination

1.5

36.6

1428

8293

N05CD07

ATC

temazepam; oral

3.6

36.6

177

416

SPAT1229

SPAT

Assessment of need for aid

3.0

36.6

225

631

A10BJ06

ATC

semaglutide; parenteral

6.2

36.5

104

141

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

5.9

36.4

107

151

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

36.4

2684

17617

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

36.4

980

5199

RD210

NOMESCO Finland

2.8

36.3

246

735

I37.0

ICD-10 Finland

Pulmonary valve stenosis

323.3

36.2

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

12.6

36.2

RD211

NOMESCO Finland

2.7

36.2

259

802

R52.9

ICD-10 Finland

Pain, unspecified

1.9

36.1

548

2427

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

43.5

36.1

C09AA04

ATC

perindopril; oral

10.7

36.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

36.0

677

3229

I49.1

ICD-10 Finland

Atrial premature depolarization

4.3

36.0

141

275

I27.0

ICD-10 Finland

Primary pulmonary hypertension

+∞

35.9

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

35.9

C09DA03

ATC

valsartan and diuretics; oral

24.6

35.8

SPAT1301

SPAT

No procedures

1.4

35.7

2390

15420

CKD40

NOMESCO Finland

Endophotocoagulation of retina

10.0

35.6

N05AH03

ATC

olanzapine; systemic

1.8

35.6

619

2876

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

5.3

35.6

114

179

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

35.6

4895

35330

XF640

NOMESCO Finland

7.0

35.6

112

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

35.5

1042

5655

E66

ICD-10 Finland

Obesity

2.4

35.2

332

1197

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

35.2

314

1099

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

35.2

525

2310

Z31.5

ICD-10 Finland

Genetic counselling

1.9

35.1

596

2749

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

162.5

35.0

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

33.3

35.0

J02AC01

ATC

fluconazole; systemic

1.4

34.9

2978

19984

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

34.9

776

3901

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

34.8

626

2943

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

34.7

622

2921

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

6.1

34.7

100

138

B02AA02

ATC

tranexamic acid; systemic

1.7

34.6

798

4051

LCA06

NOMESCO Finland

Biopsy of endometrium

1.9

34.4

512

2248

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

34.4

347

1293

K02.1

ICD-10 Finland

Caries of dentine

1.3

34.3

5604

41366

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

9.9

34.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

33.9

1472

8730

Catheter ablation of arrhythmia

+∞

33.9

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

33.9

1581

9520

C10AA03

ATC

pravastatin; oral

9.7

33.8

E87.6

ICD-10 Finland

Hypokalaemia

5.0

33.7

114

191

H3600, E103

ICD-10 Finland

3.3

33.7

181

463

N03AG01

ATC

valproic acid; systemic, rectal

1.9

33.6

500

2197

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.1

33.6

139

286

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.7

33.2

156

359

I83

ICD-10 Finland

Varicose veins of lower extremities

4.3

33.2

130

254

H05BX01

ATC

cinacalcet; oral

154.1

33.1

TFJ02

NOMESCO Finland

Muscle biopsy of heart

154.1

33.1

CKC10

NOMESCO Finland

Local photocoagulation of retina

8.5

33.1

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

33.0

874

4611

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

32.9

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

105.5

32.9

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

32.8

785

4026

UKC02

NOMESCO Finland

Cystoscopy

2.1

32.6

387

1552

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

8.2

32.6

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

32.6

1274

7388

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

32.4

895

4771

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

289.7

32.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

32.4

367

1443

JN4AD

NOMESCO Finland

Body CT examination

3.6

32.3

155

363

FFC22

NOMESCO Finland

Percutaneous transluminal closure of ostium secundum type ASD

13.8

32.2

I63.8

ICD-10 Finland

Other cerebral infarction

149.9

32.1

M04AA01

ATC

allopurinol; systemic

4.1

32.1

132

270

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

32.0

378

1512

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

102.8

32.0

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

32.0

640

3111

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

32.0

487

2158

A04AA01

ATC

ondansetron; systemic, rectal

2.2

31.9

330

1245

Q20.3

ICD-10 Finland

Discordant ventriculoarterial connection

21.5

31.9

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

31.8

221

673

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

31.8

503

2260

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

281.3

31.5

U14

ICPC

Kidney symptom/complaint

7.7

31.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.5

31.3

154

368

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.2

31.1

341

1319

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

11.3

31.0

PHM79

NOMESCO Finland

Endovenous obliteration of v.saphena anterior

11.3

31.0

WX730

NOMESCO Finland

Conventional respirator

4.9

31.0

106

180

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

+∞

31.0

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.9

31.0

129

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

35.0

31.0

WW200

NOMESCO Finland

Immunization

2.7

30.9

223

695

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

12.9

30.8

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.8

30.7

138

306

Q87.4

ICD-10 Finland

Marfan syndrome

25.0

30.6

CKC15

NOMESCO Finland

Panretinal photocoagulation

9.2

30.6

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

30.5

254

858

R01AD09

ATC

mometasone; nasal

1.3

30.4

3612

25306

I45.0

ICD-10 Finland

Right fascicular block

97.2

30.1

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.6

30.1

796

4192

R04.0

ICD-10 Finland

Epistaxis

2.6

30.1

239

787

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

30.1

515

2378

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

30.1

3603

25258

I15.0

ICD-10 Finland

Renovascular hypertension

+∞

30.0

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

+∞

30.0

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

30.0

1601

9863

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

6.4

30.0

109

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

29.9

288

1050

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

29.9

349

1390

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

29.8

1187

6897

K30

ICD-10 Finland

Functional dyspepsia

1.7

29.8

615

3018

XW000

NOMESCO Finland

Bone marrow biopsy

3.4

29.7

154

384

N03AE01

ATC

clonazepam; systemic

2.3

29.7

286

1042

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

5.4

29.6

147

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.1

29.6

361

1467

R05

ICPC

Cough

1.4

29.6

1754

11015

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

22.1

29.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

29.5

425

1843

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.4

29.4

271

968

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

29.4

338

1337

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

51.3

29.4

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

72.9

29.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

29.2

1213

7110

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

29.1

377

1569

K05

ICPC

Irregular heartbeat other

3.8

29.1

130

287

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

29.1

467

2107

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

29.1

N05AX08

ATC

risperidone; systemic

1.8

29.1

528

2488

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

28.9

1266

7501

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

19.2

28.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

28.9

417

1811

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

28.5

28.9

RS221

NOMESCO Finland

3.5

28.9

142

340

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

10.8

28.9

M79.1

ICD-10 Finland

Myalgia

1.5

28.8

986

5537

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

28.8

489

2250

Z94.4

ICD-10 Finland

Liver transplant status

13.6

28.8

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

15.7

28.7

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.3

28.6

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

7.6

28.6

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

28.5

189

560

N03AF02

ATC

oxcarbazepine; oral

2.4

28.5

264

943

PD5BD

NOMESCO Finland

Extensive CT of aorta

17.0

28.4

3025

Kela drug reimbursment

Calcium carbonate

32.5

28.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

28.3

196

597

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.2

28.3

112

222

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

20.4

28.2

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

11.9

28.2

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

28.2

223

733

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

28.1

276

1016

R31

ICD-10 Finland

Unspecified haematuria

2.4

28.1

245

849

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

28.1

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

28.1

KBV00

NOMESCO Finland

Insertion of stent into ureter

12.3

28.1

N06AB03

ATC

fluoxetine; oral

1.6

28.1

759

4018

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

28.0

690

3562

S06.0

ICD-10 Finland

Concussion

1.6

28.0

872

4783

N06AB10

ATC

escitalopram; oral

1.4

28.0

1988

12858

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

28.0

427

1894

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.5

27.9

XCD20

NOMESCO Finland

Photoangiography of eye

7.8

27.8

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021901) Oxygen saturation in Capillary blood

1027

1396

4.33

323.01

3.5

2.2

—

(3039000) Anion gap in Blood

1175

1782

3.89

322.70

8.0

5.0

11.4

11.2

mmol/l

0.63

1069

1579

(3018572) Chloride [Moles/volume] in Blood

1175

1783

3.88

322.53

8.0

5.0

105.3

105.4

mmol/l

0.33

1069

1580

(3013290) Carbon dioxide [Partial pressure] in Blood

1291

2112

3.61

320.38

4.6

2.5

5.0

kpa

0.11

1272

2062

(3010375) cycloSPORINE [Mass/volume] in Blood

520

326

9.31

320.24

29.2

22.3

121.1

134.1

ug/l

1.95

422

283

(3012501) Base excess in Blood by calculation

1290

2112

3.60

319.78

4.6

2.5

2.2

2.1

mmol/l

1.17

859

1320

(40767503) Oxygen content in Capillary blood by calculation

1190

1843

3.81

318.00

2.8

1.8

16.9

17.7

6.09

639

891

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

964

1262

4.49

316.56

1.2

1.3

—

(3022313) Gas panel - Capillary blood

2263

5283

2.55

311.31

6.4

3.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1241

2027

3.61

308.55

3.6

2.4

35.1

33.8

umol/l

0.85

1098

1730

(3044640) Blood type and Crossmatch panel - Blood

13465

50505

1.78

307.65

2.7

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

4339

8400

3.20

307.65

10.1

5.8

1.3

mmol/l

0.05

4187

8059

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12485

32683

2.69

307.65

2.4

1.5

1.1

0.8

mg/l

13.23

9501

23499

(3043409) Potassium [Moles/volume] in Arterial blood

1403

2228

3.72

307.65

4.7

3.5

3.9

3.8

mmol/l

6.18

1318

2097

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40677

215178

2.46

307.65

12.7

7.3

29.3

26.5

u/l

76.15

39855

208178

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

35197

165933

2.19

307.65

6.2

3.6

40.0

37.2

mmol/mol

307.65

33527

155471

(3013115) Eosinophils [#/volume] in Blood

22658

92202

1.88

307.65

7.8

5.8

0.2

e9/l

1.63

20392

82146

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1074

1050

6.03

307.65

1.5

1.3

352.1

356.9

pmol/l

0.05

875

804

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1715

2747

3.71

307.65

2.3

1.8

2.0

1.8

ug/l

0.27

1555

2435

(3018095) Leukocytes [#/volume] in Urine

14545

55097

1.79

307.65

4.6

2.8

66.5

67.1

e6/l

0.03

10628

35616

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4453

11894

2.29

307.65

2.8

2.3

0.2

g/l

8.62

4185

11210

(3019060) Gas panel - Arterial blood

3044

4636

4.00

307.65

5.6

3.8

—

(36304419) Bacteria [Presence] in Urine

11413

40052

1.88

307.65

3.7

2.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4580

7481

3.83

307.65

10.3

6.7

122.9

125.4

g/l

9.18

4445

7154

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5000

11270

2.77

307.65

1.9

1.5

—

(3026008) Bacteria identified in Urine by Culture

11090

40405

1.79

307.65

3.0

2.2

—

(3036489) Thrombin time

3339

4082

5.03

307.65

3.0

2.1

21.3

20.7

7.09

2796

3528

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6772

14857

2.93

307.65

3.4

1.7

23.2

25.5

25.37

5915

12905

(3016502) Oxygen saturation in Arterial blood

4903

7853

3.94

307.65

10.0

6.5

96.0

96.6

7.36

4738

7518

(3013707) Erythrocyte sedimentation rate by Westergren method

29827

135095

1.88

307.65

4.6

3.3

11.4

8.7

mm/h

216.04

28239

125969

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3060

5058

3.68

307.65

12.1

8.0

1.4

0.84

3044

5023

(3042733) HLA Ab [Presence] in Serum

548

139

23.04

307.65

5.0

3.2

—

(3023520) Reticulocytes [#/volume] in Blood

3400

7491

2.76

307.65

3.3

2.6

73.3

67.9

e9/l

9.94

2506

5473

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2027

3620

3.34

307.65

7.7

4.4

1.5

1.1

mg/l

102.40

1936

3433

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1061

1422

4.39

307.65

1.3

0.3

0.2

nmol/l

1.17

(4268621)

1249

1236

5.98

307.65

2.5

2.2

—

(3011985) Renin [Units/volume] in Plasma

1140

1165

5.78

307.65

1.6

1.9

64.8

58.8

mu/l

0.25

1046

1075

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3528

6810

3.17

307.65

11.2

6.6

24.6

24.7

mmol/l

0.73

3509

6755

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3250

7002

2.82

307.65

5.7

3.2

5.1

kpa

0.58

3059

6551

(3022948) Iron [Moles/volume] in Serum or Plasma

7737

18825

2.67

307.65

3.3

1.7

13.4

16.4

umol/l

2.15

7314

17448

(3009261) Glucose [Presence] in Urine by Test strip

20261

88909

1.59

307.65

4.0

2.8

0.0

estimate

0.84

4164

15825

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7022

13502

3.39

307.65

9.8

3.8

1.1

1.0

mmol/l

18.14

6705

12620

(3022096) Basophils/100 leukocytes in Blood

20068

80623

1.81

307.65

7.6

5.7

0.7

4.52

19063

75406

(3047181) Lactate [Moles/volume] in Blood

1656

2950

3.33

307.65

6.7

3.8

1.3

1.2

mmol/l

2.08

1476

2561

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37805

194714

1.94

307.65

4.8

3.3

4.6

4.9

mmol/l

307.65

36085

183831

(3001604) Monocytes [#/volume] in Blood

21974

88392

1.88

307.65

7.4

5.6

0.6

0.5

e9/l

81.61

19476

77655

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4016

4252

5.91

307.65

3.4

1.6

144.2

52.7

ng/l

28.46

3592

3614

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3369

8324

2.45

307.65

1.7

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2406

5610

2.56

307.65

1.7

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4703

8850

3.32

307.65

6.5

3.3

5.9

5.8

kpa

1.30

4571

8578

(3022217) INR in Platelet poor plasma by Coagulation assay

5243

9117

3.64

307.65

20.0

2.7

1.2

1.0

inr

27.70

769

1766

(3002582) Erythrocytes [#/volume] in Urine

12625

43903

1.93

307.65

4.0

2.4

73.8

74.3

e6/l

0.01

9910

32191

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

21010

67456

2.55

307.65

9.6

4.4

1.2

mmol/l

85.64

17978

56951

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

31357

131122

2.37

307.65

9.0

5.9

77.6

74.4

u/l

29.03

30071

123125

(3024561) Albumin [Mass/volume] in Serum or Plasma

18600

59861

2.39

307.65

6.4

3.9

36.1

37.2

g/l

109.24

17573

55465

(3004119) Hemoglobin [Mass/volume] in Venous blood

2965

4955

3.64

307.65

5.0

2.7

129.5

135.5

g/l

28.12

2904

4842

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10764

34563

2.06

307.65

2.4

2.0

2.9

2.6

mg/l

26.20

9475

29441

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11361

42887

1.72

307.65

1.8

1.6

1.5

1.3

mmol/l

43.75

9860

37124

(3002032) Base excess in Venous blood by calculation

4692

8806

3.33

307.65

6.6

3.3

1.6

1.8

mmol/l

1.21

3863

7029

(3027945) Reticulocytes/100 erythrocytes in Blood

4592

10917

2.60

307.65

3.5

2.7

1.8

1.6

33.97

4189

9711

(3024928) Oxygen saturation in Venous blood

1309

1626

4.76

307.65

5.6

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

40373

192722

4.01

307.65

18.9

7.5

139.5

139.8

mmol/l

62.01

39860

186368

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19866

80616

1.78

307.65

4.4

3.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

38195

196564

2.02

307.65

5.1

3.5

2.8

3.0

mmol/l

307.65

36255

184167

(3013826) Glucose [Moles/volume] in Serum or Plasma

25877

86266

2.81

307.65

6.3

3.2

6.7

6.3

mmol/l

114.14

24571

77475

(1616796) Gas panel - Central venous blood

1280

2064

3.66

307.65

4.5

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5599

17495

1.97

307.65

3.7

2.5

7.4

6.9

umol/l

1.11

4809

14922

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1939

963

12.12

307.65

5.9

2.4

0.3

u/ml

3.25

1107

372

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13835

48466

1.95

307.65

3.3

2.2

55.7

58.3

u/l

3.47

12998

44680

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2322

3795

3.68

307.65

4.6

2.9

1.4

0.76

2309

3772

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2351

3940

3.59

307.65

4.3

2.4

3.4

3.5

g/l

1.77

2256

3725

(3032080) INR in Blood by Coagulation assay

18316

42495

3.58

307.65

8.7

2.6

1.2

1.0

inr

57.94

5805

13538

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12086

17336

5.19

307.65

3.5

1.5

1000.0

291.7

ng/l

50.31

10205

12877

(3009508) Creatinine [Moles/volume] in Urine

13998

38810

2.60

307.65

4.0

2.9

7.9

8.9

mmol/l

2.21

12271

33348

(3031040) Bacteria [#/volume] in Urine by Automated count

25504

115138

1.68

307.65

4.7

3.3

1537.3

1225.1

e6/l

0.34

390

1221

(3010421) pH of Blood

1460

2527

3.42

307.65

4.7

2.4

7.4

0.83

1273

2062

(3000991) Gas panel - Venous blood

4401

8235

3.32

307.65

12.7

6.5

—

(3012516) Albumin [Mass/volume] in Urine

12489

29847

2.99

307.65

3.9

2.8

389.6

491.8

mg/l

1.32

8454

17540

(4306422)

1885

1611

7.02

307.65

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

343

32.19

307.65

6.7

5.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4534

12172

2.29

307.65

3.3

2.3

—

(3003396) Base excess in Arterial blood by calculation

5448

9137

3.79

307.65

9.5

6.1

0.8

mmol/l

0.39

4286

6919

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39492

198446

2.66

307.65

17.2

8.1

21.2

20.9

mg/l

0.76

33055

144603

(3007930) Methemoglobin/Hemoglobin.total in Blood

1878

3193

3.50

307.65

6.2

3.7

0.9

0.38

1769

2965

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37595

193503

1.91

307.65

4.7

3.3

1.4

1.5

mmol/l

307.65

35776

182330

(3014007) Fractional oxyhemoglobin in Arterial blood

3063

5070

3.68

307.65

12.3

8.0

94.0

94.8

9.43

3052

5051

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2812

4439

3.84

307.65

12.8

7.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2544

5619

2.71

307.65

2.2

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

11568

39758

1.93

307.65

3.8

2.4

0.3

e6/l

3.44

8860

28436

(3019309) Folate [Moles/volume] in Red Blood Cells

6505

20243

2.01

307.65

1.8

1.6

1200.1

1133.0

nmol/l

6.69

5297

15345

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7201

16723

2.78

307.65

3.3

1.7

2.4

2.5

g/l

31.27

6797

15402

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2098

3500

3.59

307.65

2.1

1.7

1.5

1.3

g/l

8.68

1827

2988

(3027456) Digoxin [Moles/volume] in Serum or Plasma

471

104

26.43

307.65

2.9

2.6

0.8

0.9

nmol/l

0.44

349

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5033

11954

2.62

307.65

4.7

4.3

240.1

232.2

u/l

1.89

4820

11351

(3014576) Chloride [Moles/volume] in Serum or Plasma

6018

11737

3.28

307.65

8.9

6.0

104.6

104.8

mmol/l

3.73

5900

11531

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3863

5059

4.74

307.65

2.4

1.4

10.0

3.3

ug/l

29.34

3487

4303

(3009343) pH of Capillary blood

3214

6923

2.82

307.65

5.8

3.2

7.4

6.16

465

691

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1344

1065

7.49

307.65

1.2

1.1

94.5

96.5

1.19

1289

989

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2671

3531

4.59

307.65

3.4

2.6

175.7

161.1

11.64

2563

3334

(3000850) Epithelial cells [#/volume] in Urine

9036

28996

2.01

307.65

3.3

2.0

6.3

6.4

e6/l

0.25

8115

24858

(3023103) Potassium [Moles/volume] in Serum or Plasma

40468

193615

4.06

307.65

19.1

7.5

3.9

mmol/l

23.27

39912

186714

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3118

3609

5.30

307.65

3.7

2.3

95.2

93.5

2.53

2885

3368

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

16682

43840

2.94

307.65

3.6

1.8

57.7

16.5

ng/l

3.33

10105

18511

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5434

9116

3.79

307.65

9.5

6.1

5.1

kpa

0.04

5227

8683

(3019198) Lymphocytes [#/volume] in Blood

22542

92283

1.85

307.65

7.4

5.5

1.9

2.0

e9/l

4.78

20320

82601

(3026493) Urate [Moles/volume] in Serum or Plasma

11509

37570

2.05

307.65

2.9

1.9

2395.0

3341.1

umol/l

2.50

10387

33610

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3110

6717

2.80

307.65

5.8

3.3

1.5

1.2

mmol/l

3.64

2299

4803

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1790

1881

5.69

307.65

1.3

1.2

4.0

3.0

u/ml

0.87

607

687

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1059

1442

4.32

307.65

1.3

0.7

1.3

nmol/l

0.32

1023

1395

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8280

14488

3.84

307.65

3.2

1.8

30.0

28.9

46.48

8073

14033

(3006315) Basophils [#/volume] in Blood

22049

88724

1.88

307.65

7.4

5.6

0.0

e9/l

12.69

19528

77814

(42870588) Differential panel, method unspecified - Blood

15613

55985

1.95

307.65

7.3

5.8

—

(3019069) Monocytes/100 leukocytes in Blood

20714

84084

1.81

307.65

7.9

5.8

8.4

8.2

9.74

19763

79206

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6633

22611

1.82

307.65

3.4

2.3

3.3

3.4

e6/l

0.19

3532

11518

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

36897

181915

2.14

307.65

14.8

6.9

88.6

91.6

ml/min/173m2

117.58

31514

144425

(3027273) Bicarbonate [Moles/volume] in Venous blood

2166

3863

3.36

307.65

4.8

2.4

25.1

25.3

mmol/l

1.73

2090

3722

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2698

6706

2.41

307.65

1.6

1.4

—

(40758558) Short blood count panel - Blood

11216

43216

1.67

307.65

8.0

6.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2829

5257

3.25

307.65

7.6

3.8

24.0

24.2

mmol/l

1.40

2585

4805

(40761511) CBC panel - Blood by Automated count

40322

213844

2.25

307.65

15.6

7.5

—

(3037522) Nuclear Ab [Titer] in Serum

7405

25569

1.81

307.65

1.4

495.9

547.3

titre

1.34

1438

4735

(3005719) IgG [Mass/volume] in Serum or Plasma

4295

12146

2.16

307.65

2.9

2.5

10.4

10.5

g/l

1.10

3975

11120

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9447

19135

3.37

307.65

4.0

1.9

641.0

152.5

ng/l

18.39

6583

9496

(3021960) Folate [Moles/volume] in Serum or Plasma

8634

28675

1.92

307.65

1.6

1.4

19.9

20.9

nmol/l

7.64

7738

24907

(3033658) Prothrombin time (PT) actual/Normal

12644

37141

2.36

307.65

5.3

3.0

92.7

97.3

74.53

12304

36163

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3637

7356

3.02

307.65

6.2

2.5

100.4

61.0

ng/l

71.96

3307

6539

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14907

57151

1.77

307.65

2.0

1.6

97.0

99.5

pmol/l

8.03

8289

29789

(3020682) Albumin/Creatinine [Ratio] in Urine

13051

31236

3.02

307.65

4.7

3.5

13.5

5.4

mg/mmol

38.20

8867

18849

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17294

71756

1.65

307.65

2.8

2.1

73.1

1309.5

nmol/l

0.50

16206

66427

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7019

17777

2.53

307.65

2.0

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

705

211

19.59

307.65

40.5

33.4

7.6

7.1

ug/l

3.05

665

188

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3707

9634

2.34

307.65

4.8

2.7

1.2

mmol/l

7.32

3364

8204

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13517

36324

2.67

307.65

2.4

1.8

205.4

204.8

u/l

0.02

12899

34148

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1626

2595

3.72

307.65

8.7

3.9

871.0

588.8

iu/ml

0.76

280

235

(3013650) Neutrophils [#/volume] in Blood by Automated count

24587

102719

1.88

307.65

10.9

8.4

4.1

3.8

e9/l

76.48

21892

90050

(3037467) Urinalysis macro (dipstick) panel - Urine

27186

124062

1.71

307.65

4.8

3.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31693

151111

1.78

307.65

4.4

3.8

14.6

14.4

pmol/l

51.58

29815

139659

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1836

1505

7.31

307.65

1.1

116.5

118.9

1.80

1714

1358

(3012544) pH of Venous blood

4888

9012

3.40

307.65

6.5

3.2

7.4

1.56

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2555

4330

3.56

307.65

13.0

8.2

24.1

24.2

mmol/l

1.47

2423

4106

(3020779) Urea [Moles/volume] in Serum or Plasma

5187

6887

4.80

307.65

12.2

4.5

8.6

6.2

mmol/l

106.09

5039

6589

(3021589) Normoblasts [#/volume] in Blood

19491

79971

1.74

307.65

11.3

7.2

0.0

e9/l

1.53

16257

65368

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5435

14402

2.35

307.65

2.3

2.1

359.0

378.9

nmol/l

10.25

5059

13374

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36499

182812

1.96

307.65

4.6

3.2

6.0

5.6

mmol/l

307.65

34373

170149

(3023368) Bacteria identified in Blood by Culture

11475

29945

2.65

307.65

5.0

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3371

9193

2.21

307.65

1.8

1.2

1.3

g/l

1.72

3134

8505

(3035350) Ketones [Presence] in Urine by Test strip

20108

87628

1.61

307.65

4.0

2.7

0.0

estimate

0.35

4238

15499

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1303

1850

4.16

307.65

5.2

2.4

7753.2

9488.0

u/ml

0.07

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3060

5047

3.69

307.65

12.2

8.0

0.7

0.09

3043

5017

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1413

2109

3.97

307.65

4.4

2.5

24.1

24.4

mmol/l

1.20

1262

1866

(3021601) Nitrite [Presence] in Urine by Test strip

20096

88125

1.59

307.65

5.4

3.8

0.0

estimate

0.44

4385

16151

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8639

17588

3.29

307.65

5.0

3.2

0.8

mmol/l

24.10

8234

16368

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1755

1785

5.87

307.65

1.3

1.2

4.4

3.7

u/ml

1.24

806

789

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10365

37641

1.78

307.65

2.6

1.9

—

(40768446) Kidney Pathology biopsy report

518

238

12.71

307.65

2.0

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1943

3607

3.21

307.65

4.9

2.7

52.0

48.6

5.57

1919

3567

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19605

87293

1.54

307.65

3.5

2.6

120.2

87.5

ug/l

22.12

18659

82478

(3018010) Neutrophils/100 leukocytes in Blood

20911

86855

1.75

307.65

7.4

5.4

57.1

55.4

89.43

19933

81835

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7073

23849

1.85

307.65

3.2

2.2

1.0

e6/l

0.13

3967

12695

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22233

78658

2.30

307.65

7.1

5.1

10.9

10.7

umol/l

1.41

21218

73885

(3002385) Erythrocyte distribution width [Ratio]

33981

173176

1.61

307.65

20.6

10.1

13.6

13.4

74.32

33533

169167

(3027801) Oxygen [Partial pressure] in Arterial blood

5434

9112

3.79

307.65

9.4

6.1

12.8

14.3

kpa

44.33

5220

8683

(3015736) pH of Urine

15830

67129

1.57

307.65

3.7

2.6

5.7

5.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

1629

2585

3.74

307.65

4.5

3.3

1.3

1.4

mmol/l

0.15

1607

2538

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1888

3265

3.45

307.65

6.1

3.6

1.8

1.02

1776

3031

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8118

28886

1.77

307.65

1.7

1.5

40251280.7

39373142.5

pmol/l

0.04

7016

24837

(3002030) Lymphocytes/100 leukocytes in Blood

21222

88050

1.77

307.65

7.6

5.5

28.4

30.5

145.38

20192

82547

(3024354) Oxygen [Partial pressure] in Venous blood

3845

7391

3.20

307.65

5.6

3.2

4.9

4.8

kpa

2.68

3725

7145

(3026782) Osmolality of Urine

8384

26675

2.01

307.65

3.4

2.1

531.7

562.6

mosm/kgh2o

18.61

7387

22366

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15960

58485

1.91

307.65

4.0

2.9

34.1

30.4

u/l

4.45

15277

55709

(3020564) Creatinine [Moles/volume] in Serum or Plasma

41123

212518

3.24

307.65

19.1

8.4

76.1

70.5

umol/l

147.29

41117

212378

(3020630) Protein [Mass/volume] in Serum or Plasma

3314

7231

2.78

307.65

2.6

2.4

66.4

67.8

g/l

16.70

3095

6664

(3027315) Oxygen [Partial pressure] in Blood

1301

2113

3.63

307.65

4.6

2.5

9.0

9.2

kpa

2.85

1281

2063

(3018418) pH of Serum or Plasma

13005

38276

2.37

307.65

5.5

2.9

7.4

0.46

2825

6660

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2262

3735

3.63

307.65

4.6

2.9

0.7

0.73

2181

3528

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36273

179275

2.03

307.65

5.3

4.2

1.9

2.1

mu/l

1.86

34391

167339

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3828

10956

2.12

307.65

2.9

2.0

69.7

81.9

ml/min/173m2

37.38

1538

3601

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2974

4719

3.83

307.65

7.9

5.4

24.4

24.5

mmol/l

0.38

2797

4311

(3006504) Eosinophils/100 leukocytes in Blood

20647

83552

1.81

307.65

7.6

5.6

2.8

2.9

7.68

19590

78129

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1770

3047

3.45

307.65

2.9

1.9

589.5

352.4

ug/l

0.92

1660

2700

(3007853) Bacteria identified in Skin by Aerobe culture

5718

17828

1.98

307.65

2.0

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5054

11431

2.76

307.65

1.9

1.5

—

(3042936) Bacteria identified in Isolate by Culture

6713

18885

2.25

307.65

2.4

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

13347

50093

1.78

307.65

3.7

3.0

2.3

2.4

mmol/l

4.11

12099

44637

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1832

1674

6.55

307.65

1.1

—

(3013512) EKG study

11504

36225

2.13

307.65

3.7

2.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

36627

185549

1.90

307.65

4.2

3.0

1.4

1.2

mmol/l

199.50

34702

174395

(3044889) 12 lead EKG panel

29671

113467

2.61

307.65

3.9

2.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2402

5207

2.76

307.65

1.6

1.5

14.4

11.3

u/ml

0.46

174

(3020891) Body temperature

1850

3204

3.44

307.65

5.6

3.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19224

60385

2.50

307.65

8.8

4.1

1.2

mmol/l

99.40

17945

54359

(3017181) Myelocytes/100 leukocytes in Blood

4054

12298

2.00

302.09

4.7

4.1

0.9

0.61

1181

2753

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2119

4870

2.59

300.40

2.1

1.7

1.2

1.1

g/l

8.83

2034

4642

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1953

4309

2.69

299.29

1.7

1.6

371.4

368.4

titre

0.01

167

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2063

4710

2.61

296.17

2.1

1.7

0.2

g/l

13.08

1979

4474

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

624

561

6.50

295.88

1.3

1.1

—

(3024932) HLA-DR beta [Type]

448

255

10.24

292.38

1.1

1.3

—

(3024471) HLA-A [Type]

452

268

9.83

287.99

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

794

955

4.87

286.09

7.8

5.4

10.8

9.9

mg/l

3.93

740

882

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2448

6216

2.35

281.88

2.3

1.9

38.5

41.0

u/l

6.50

2190

5898

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1154

1912

3.55

281.07

2.8

2.2

194.9

37.3

ug/min

11.97

761

1182

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1354

2500

3.20

280.94

1.8

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1328

2426

3.23

280.13

1.9

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3726

11309

1.99

276.01

4.4

3.9

0.6

0.05

864

2035

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15668

69470

1.47

275.72

4.1

2.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6586

23912

1.70

275.67

3.0

2.6

2.4

mmol/l

20.42

5751

20972

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

580

522

6.49

274.75

1.1

1.0

95.2

94.8

0.09

488

410

(3029937) Albumin [Presence] in Urine by Test strip

11026

45468

1.54

274.41

4.4

3.0

0.0

estimate

0.59

4185

15857

(3028626) Oxygen [Partial pressure] in Capillary blood

1496

2982

2.96

274.14

7.2

4.5

9.0

9.2

kpa

4.24

1413

2816

(3021440) Promyelocytes/100 leukocytes in Blood

3826

11845

1.95

267.61

4.7

4.2

0.1

0.2

1.10

1095

2539

(3011397) Hemoglobin [Presence] in Urine by Test strip

9549

38471

1.56

261.51

3.9

2.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1517

3211

2.79

250.18

1.9

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1097

1907

3.38

249.15

3.2

3.3

1.9

2.7

ratio

0.41

108

183

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1124

1988

3.32

248.81

3.3

3.4

48.4

29.4

mg/l

1.70

895

1644

(3025159) Blasts/100 leukocytes in Blood

3640

11346

1.93

248.80

4.8

4.2

0.1

0.2

0.16

932

2166

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28464

142721

1.44

247.67

3.8

2.6

50.7

36.4

u/l

128.37

27164

135909

(40768797) Stomach Pathology biopsy report

5889

21299

1.69

247.50

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

908

1384

3.85

247.44

2.0

1.6

1.7

1.8

mmol/l

1.19

887

1355

(3034860) Kappa light chains.free [Mass/volume] in Serum

1123

1996

3.31

246.75

3.3

3.4

57.8

57.9

mg/l

0.00

892

1645

(3034426) Prothrombin time (PT)

444

325

7.96

246.62

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1173

2152

3.21

245.55

4.9

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1296

2532

3.02

245.30

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

703

871

4.72

245.27

1.2

1.1

1.0

ratio

1.80

250

328

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1653

3739

2.61

240.81

2.4

1.9

11.2

9.6

mg/l

7.20

1541

3558

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4347

14506

1.81

240.68

3.3

2.2

45.7

41.6

u/l

0.15

3776

12477

(3011648) Oxygen content in Venous blood

600

662

5.29

236.09

4.7

5.9

11.4

11.5

0.27

600

662

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1518

3396

2.64

225.68

1.5

1.3

12.4

13.7

iu/ml

0.12

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1609

3723

2.55

224.00

2.0

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1968

5039

2.31

221.28

6.6

3.5

24.6

24.5

mmol/l

1.14

1877

4798

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1525

3482

2.58

217.86

2.0

1.2

111.9

103.9

u/ml

1.33

321

751

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1592

3722

2.53

217.00

1.9

1.2

18.1

22.4

u/ml

0.54

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1440

3216

2.64

214.67

2.2

2.0

3.8

3.7

g/l

1.11

1086

2307

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1440

3220

2.64

214.15

2.2

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1440

3223

2.63

213.77

2.2

2.0

7.3

7.0

g/l

8.25

1128

2492

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

976

1746

3.28

212.19

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

10327

44167

1.46

204.02

5.2

3.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1343

2980

2.65

202.57

2.2

2.0

10.2

10.3

g/l

0.19

1168

2517

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

221

22.50

201.70

9.0

5.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

857

1457

3.44

200.87

3.3

3.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

550

655

4.90

200.17

1.2

1.1

23.4

4.4

u/ml

1.48

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

819

1357

3.53

199.15

1.7

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1371

3104

2.60

198.92

2.2

2.0

3.1

2.9

g/l

6.87

1109

2428

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1565

3793

2.43

197.88

1.6

1.2

258.8

239.8

u/ml

1.65

1082

2364

(3000494) Fungus identified in Specimen by Culture

5200

19294

1.63

194.33

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

954

1784

3.13

193.54

1.6

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

216

20.89

192.70

5.2

4.8

2.3

2.2

mg/l

0.08

191

(3038071) Oxygen [Partial pressure] in Mixed venous blood

208

23.66

192.64

9.0

5.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1619

4056

2.36

190.58

1.6

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

729

1151

3.70

189.45

1.9

1.5

90.6

91.2

2.00

719

1132

(3019150) Specific gravity of Urine by Refractometry

8967

37764

1.47

189.34

4.2

2.9

1.0

kg/l

0.79

1282

5568

(40761535) Cells panel - Urine sediment

3217

10578

1.82

184.34

4.0

2.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8079

33512

1.48

183.22

1.3

30.0

30.8

iu/ml

0.08

2541

10491

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

925

1761

3.08

182.32

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

712

1138

3.66

181.98

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

810

1420

3.34

181.45

1.5

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1231

2771

2.61

180.46

2.3

2.1

0.7

g/l

0.24

1110

2442

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1202

2676

2.64

179.98

4.7

1.7

1.0

0.7

nmol/l

16.21

1005

2311

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1140

2480

2.70

178.28

2.1

1.9

0.0

g/l

0.67

1065

2305

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1144

2504

2.68

176.87

2.1

1.9

37.8

39.8

g/l

16.96

1021

2179

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1055

2213

2.80

176.31

2.2

1.9

0.0

g/l

0.00

989

2065

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1062

2237

2.78

176.16

2.2

1.9

0.0

g/l

0.75

990

2067

(3007461) Platelets [#/volume] in Blood

42014

233767

2.18

173.01

25.3

12.3

260.0

259.3

e9/l

1.19

41435

227490

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1100

2394

2.70

171.85

2.5

1.8

132.4

136.0

g/l

4.49

859

1707

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1280

3017

2.49

171.19

2.6

2.5

—

(3037121) Protein [Mass/volume] in Urine

1672

4457

2.21

170.59

4.4

3.1

0.4

0.2

g/l

4.81

906

1946

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

149

71.94

168.40

7.4

4.9

6.0

5.2

mmol/l

0.75

149

(3041096) Erythrocytes [Presence] in Urine by Automated

11464

51405

1.39

167.88

3.5

2.4

—

(3003181) Sodium [Moles/volume] in Urine

739

1284

3.36

167.73

1.6

67.5

70.3

mmol/l

0.62

587

979

(3034770) Mitochondria Ab [Titer] in Serum

1658

4448

2.20

166.55

1.3

860.9

1004.5

titre

0.33

131

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

909

1814

2.93

165.66

1.5

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1040

2242

2.72

165.33

1.3

1.2

190.4

142.8

titre

0.19

(3035941) MCH [Entitic mass]

42017

234090

2.14

164.04

25.2

12.2

30.1

2.54

41762

230957

(3024731) MCV [Entitic volume]

42021

234126

2.15

163.89

25.2

12.2

90.4

90.0

43.04

41769

230974

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7573

31627

1.46

163.52

1.3

9.1

9.9

u/ml

0.54

3137

13186

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3456

12013

1.72

163.27

3.4

4.5

4.6

pmol/l

6.16

3138

10807

(3026361) Erythrocytes [#/volume] in Blood

42022

234167

2.14

162.90

25.3

12.2

4.5

4.6

e12/l

84.29

41377

227406

(3010813) Leukocytes [#/volume] in Blood

42024

234246

2.13

161.02

25.3

12.3

6.9

6.5

e9/l

182.18

41385

227433

(3000963) Hemoglobin [Mass/volume] in Blood

42025

234289

2.13

159.97

25.4

12.3

136.2

138.0

g/l

121.04

41772

231162

(3007566) Smooth muscle Ab [Titer] in Serum

1678

4613

2.14

158.71

1.3

93.7

134.7

titre

1.33

163

430

(3020876) Protein [Mass/time] in 24 hour Urine

463

587

4.59

157.49

2.0

2.1

1.1

1.2

g/24h

0.17

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

673

1146

3.43

157.32

1.8

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

643

1061

3.54

157.22

1.5

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

9461

41475

1.41

155.96

1.5

1.4

2.4

2.2

g/l

21.25

6221

26045

(4094501)

1320

3312

2.34

154.50

1.1

1.0

—

(44806118)

718

1293

3.24

154.40

1.8

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

925

1941

2.79

154.40

1.6

—

(44790048)

718

1294

3.24

154.22

1.8

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4561

17275

1.59

154.14

7.1

3.7

—

(44790049)

717

1293

3.24

153.86

1.8

1.5

—

(44790047)

717

1294

3.24

153.67

1.8

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

396

449

5.13

151.67

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

757

1427

3.10

151.53

1.3

29.9

24.9

nmol/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

246

155

9.21

151.09

7.8

3.1

24.8

24.2

mmol/l

0.75

234

146

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

725

1371

3.09

144.38

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1434

3849

2.19

143.61

3.3

2.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

578

951

3.54

141.91

3.3

2.0

93.9

102.3

5.64

546

867

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

328

334

5.71

139.44

3.2

2.5

—

(3037756) Immunofixation for Serum or Plasma

724

1400

3.02

139.04

1.6

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2186

6937

1.86

138.84

3.5

2.0

0.3

0.2

e6/l

0.45

2122

6673

(3004775) Volume in Urine collected for unspecified duration

413

534

4.50

137.45

2.6

2.0

697.5

597.6

3.88

319

395

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

371

442

4.88

135.04

1.2

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1016

2402

2.48

134.84

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1015

2402

2.47

134.44

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1807

5437

1.96

134.20

2.3

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2081

20606

0.56

133.94

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

880

1948

2.64

133.02

1.6

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2219

7174

1.83

132.83

1.3

1.2

1.1

0.8

u/ml

0.39

189

556

(3008037) Lactate [Moles/volume] in Venous blood

820

1755

2.73

132.01

3.3

1.9

1.5

1.4

mmol/l

1.57

804

1714

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

935

2144

2.55

131.97

1.2

1.3

—

(3016750) Collection duration of Urine

353

410

5.00

131.96

2.6

1.8

500.9

507.5

min

0.52

287

325

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

131

32.98

131.70

7.5

8.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

613

1121

3.19

128.74

1.4

11.8

10.1

umol/l

7.69

592

1058

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1371

3815

2.11

125.44

1.5

1.3

282.2

305.2

ug/g

3.09

790

2001

(3012565) Volume of 24 hour Urine

363

457

4.62

124.51

2.2

2.1

2031.0

2142.8

0.74

344

421

(3004451) EKG impression Narrative

236

188

7.28

123.33

1.3

1.1

—

(4035726)

3470

12992

1.59

121.43

1.5

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

413

598

4.02

120.17

1.5

1.3

34.3

39.6

g/l

9.90

368

557

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

970

2377

2.39

119.34

2.4

2.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6693

28776

1.41

118.84

1.9

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

412

601

3.99

118.77

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

648

1292

2.92

118.23

1.1

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

200

135

8.59

117.57

1.3

1.2

380.0

350.7

pmol/l

0.13

146

105

(3038515) Glucose [Moles/volume] in Venous blood

753

1639

2.68

117.49

3.3

1.9

7.6

7.0

mmol/l

3.82

737

1612

(3048929) Epstein Barr virus Ab [Presence] in Serum

2311

7844

1.74

117.35

1.5

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

421

631

3.88

117.25

1.1

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1497

4421

1.99

116.92

1.5

1.4

486.5

469.8

mg/l

0.37

1432

4216

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

647

1317

2.86

113.92

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

697

1482

2.74

113.56

1.3

37.3

27.2

u/l

0.84

610

1288

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1350

3883

2.04

113.23

1.7

1.5

4438.9

580.7

e6/l

0.80

1112

3077

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1348

3877

2.04

113.08

1.6

1.4

29.8

22.5

e6/l

0.47

1073

2923

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10528

48969

1.32

112.11

1.3

1.5

1.7

u/ml

1.18

3033

13773

(4010399)

2939

10776

1.62

111.68

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

583

1137

2.99

110.42

1.8

—

(40761536) Microorganisms panel - Urine sediment

3823

14944

1.52

110.17

4.5

2.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3202

12066

1.57

108.50

4.0

4.1

20.3

23.6

ug/l

0.22

2479

9050

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1339

3909

2.01

107.86

1.4

1.3

3.8

3.5

mmol/l

10.31

1252

3676

(3022493) Free Hemoglobin [Mass/volume] in Plasma

330

440

4.36

106.12

8.5

1.4

2084.0

4675.1

mg/l

0.81

274

276

(21494890) Protein electrophoresis panel - 24 hour Urine

401

627

3.72

105.67

2.0

2.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

406

650

3.63

103.62

1.6

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

463

820

3.28

102.19

2.4

1.7

4.0

mmol/l

1.64

457

813

(3023419) Bacteria identified in Sputum by Culture

550

1086

2.95

102.05

2.7

2.9

—

(3035285) Chloride [Moles/volume] in Venous blood

462

819

3.28

101.83

2.4

1.7

105.2

106.1

mmol/l

2.95

456

812

(3035637) Corticotropin [Mass/volume] in Plasma

822

2018

2.38

100.71

1.7

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8542

39094

1.33

99.92

3.8

3.9

1.9

2.6

ug/l

3.28

7766

35909

(3023199) Leukocytes [#/volume] in Pleural fluid

381

601

3.68

99.25

1.5

1.3

3215.0

6156.4

e6/l

1.34

263

440

(3051593) INR in Capillary blood by Coagulation assay

165

108

8.85

99.03

7.6

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

515

997

3.01

98.77

1.4

1.5

1.3

nmol/l

4.83

462

908

(3005322) IgE [Units/volume] in Serum or Plasma

3491

13702

1.51

98.13

1.4

1.3

208.5

248.9

u/ml

1.22

3269

12753

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

386

621

3.61

97.89

1.6

1.5

23.0

2.7

nmol/l

0.76

319

505

(3044290) Cell count panel - Cerebral spinal fluid

1255

3714

1.98

97.30

1.6

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

158

100

9.15

96.88

5.9

3.5

41.9

30.9

ug/min

0.66

118

(3040151) Glucose [Moles/volume] in Capillary blood

566

1176

2.80

96.17

5.4

2.7

7.3

6.9

mmol/l

1.29

483

949

(3004809) Band form neutrophils/100 leukocytes in Blood

748

1807

2.41

94.86

3.4

2.8

1.3

1.4

0.57

605

1396

(3033705) Calcium.ionized [Moles/volume] in Venous blood

444

807

3.20

94.22

2.4

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

766

1895

2.36

92.31

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

381

638

3.47

91.37

1.9

1.6

—

(3045788) Cell count panel - Pleural fluid

314

457

3.99

90.89

1.5

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

481

941

2.97

90.69

3.2

2.5

102.4

39.0

mg/l

2.54

363

629

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

246

292

4.89

90.04

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1614

5328

1.78

89.64

2.1

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

606

1358

2.60

89.49

1.8

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

994

2786

2.08

89.11

1.6

0.8

0.7

g/l

0.42

725

2160

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1479

4770

1.82

88.63

1.9

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1104

11672

0.53

87.65

1.5

—

(3022145) Colonoscopy Study observation

4559

19255

1.41

87.18

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

176

151

6.75

86.92

1.4

1.6

124.2

69.1

mu/l

0.68

140

128

(3042111) Morphology [Interpretation] in Bone marrow Narrative

641

1500

2.49

86.86

1.8

—

(3019225) pH of Specimen

3401

13602

1.48

86.82

5.2

2.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1022

11008

0.52

86.29

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

340

547

3.61

86.28

1.5

1.3

57312.7

51510.0

e6/l

0.10

193

335

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1022

11001

0.53

86.11

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1015

10947

0.52

86.07

1.4

—

(3012441) Differential panel - Pleural fluid

332

528

3.65

85.60

1.5

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1023

10978

0.53

85.30

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1404

13733

0.58

84.20

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1080

3191

1.98

84.05

1.1

—

(3019977) pH of Arterial blood

271

373

4.22

84.04

3.0

2.3

7.4

0.62

113

(3023487) Leukocytes [#/volume] in Peritoneal fluid

202

211

5.55

84.03

2.6

1.6

613.2

3737.8

e6/l

0.72

140

120

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

41.02

81.73

3.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

984

2850

2.02

80.88

1.1

84.4

4160.1

iu/ml

0.76

225

751

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6604

29908

1.32

80.86

2.0

1.7

1.5

1.3

40.88

5882

27214

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

174

161

6.26

80.74

2.8

2.3

37.4

21.4

mg/l

0.51

(3027923) C peptide [Moles/volume] in Serum or Plasma

346

591

3.40

80.69

1.7

2.1

1.2

1.3

nmol/l

0.46

269

487

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1060

3169

1.95

79.80

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

367

663

3.21

78.70

4.2

3.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

438

894

2.85

76.88

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

438

894

2.85

76.88

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

438

894

2.85

76.88

1.6

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

313

520

3.49

76.00

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

15291

77079

1.22

75.96

2.0

1.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

104

12.28

75.25

5.1

4.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

810

8970

0.51

74.56

1.4

1.5

—

(3042631) Mycobacterium sp identified in Specimen

507

1141

2.58

74.32

2.6

2.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

796

2199

2.11

74.05

1.1

1.5

1.4

g/l

10.15

730

2002

(3043238) Trisomy 21 risk [Likelihood] in Fetus

839

9169

0.52

74.00

1.5

—

(3005033) Fetal Nuchal fold Thickness US

811

8951

0.51

73.84

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

101

12.43

73.53

4.9

4.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

180

192

5.43

73.46

2.3

1.5

15096.9

15791.5

e6/l

0.02

(3003694) ABO and Rh group [Type] in Blood

12284

60672

1.24

73.44

1.5

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

225

297

4.39

73.36

2.2

1.9

—

(3036603) Volume of Urine

381

738

3.00

73.13

1.7

1.6

2053.5

2059.8

0.02

112

(21494755) Public health laboratory ask at order entry panel

4462

33696

0.74

72.56

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

147

127

6.70

72.26

1.5

1.2

12.8

g/l

0.02

100

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1246

4065

1.79

71.83

3.5

3.7

1457.6

676.9

u/ml

0.46

1078

3509

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

549

1310

2.44

71.53

1.2

79.6

69.4

u/l

0.46

413

861

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1487

5125

1.70

70.92

1.3

34.7

32.6

u/ml

0.11

310

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

533

1262

2.46

70.58

1.2

78.1

162.5

titre

0.77

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1362

4589

1.74

70.40

1.3

9.9

6.6

u/ml

0.35

142

445

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

532

1267

2.44

69.60

1.2

247.7

197.2

titre

0.50

215

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

17.15

69.33

7.2

4.5

—

(3025941) Bacteria identified in Stool by Culture

2857

11530

1.46

69.05

1.3

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1016

3147

1.88

68.94

2.3

2.1

8.8

7.4

titre

0.13

123

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1375

4675

1.72

68.84

1.3

11.1

9.2

u/ml

0.38

215

684

(3044927) Protein electrophoresis panel - Urine

345

653

3.07

68.80

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

282

468

3.50

68.63

1.6

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

19.62

68.30

6.9

1.9

70.9

23.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1003

3106

1.89

68.11

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

665

1768

2.19

68.02

1.4

1.3

6.7

g/l

0.03

444

1255

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

525

1257

2.43

67.94

2.2

2.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1119

3598

1.82

67.61

1.3

1.2

5.7

4.8

u/ml

0.12

267

(4062490)

664

1769

2.19

67.59

1.4

—

(3011412) CD3 cells [#/volume] in Blood

652

1725

2.20

67.48

2.3

2.8

1.2

1.3

e9/l

0.55

419

978

(3024139) IgG subclass 3 [Mass/volume] in Serum

662

1766

2.18

67.17

1.4

1.3

0.4

g/l

0.51

442

1257

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

278

464

3.48

67.12

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

315

572

3.20

67.09

1.4

1.2

6.1

5.5

mmol/l

3.83

286

514

(3028192) IgG subclass 2 [Mass/volume] in Serum

662

1767

2.18

67.08

1.4

1.3

2.8

3.0

g/l

1.63

445

1254

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

266

431

3.58

66.96

1.4

1.2

393.1

870.3

u/l

3.82

253

407

(3017569) Oxygen content in Arterial blood

201

261

4.46

66.82

2.3

1.9

—

(40768806) Pleura Pathology biopsy report

310

562

3.20

66.20

1.6

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

402

852

2.74

66.05

1.8

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

947

2908

1.90

65.95

1.7

1.6

12795.8

9823.0

e6/l

1.12

685

2147

(3044007) Cell count panel - Peritoneal fluid

165

180

5.31

65.93

2.4

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

572

1450

2.29

65.39

1.7

1.5

1.3

1.5

promille

1.85

424

1133

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1090

3516

1.81

65.18

1.2

28.5

18.2

u/ml

0.26

(3016038) Potassium [Moles/volume] in Urine

300

538

3.24

65.16

1.6

1.7

34.5

35.7

mmol/l

0.29

271

476

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

418

916

2.65

64.56

2.8

2.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

155

162

5.54

64.55

4.7

3.8

1.2

mmol/l

0.34

149

154

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4254

18610

1.35

64.46

1.6

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

499

1196

2.43

64.46

3.9

2.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

258

421

3.55

64.33

1.9

1.5

18344.7

1318.2

u/ml

0.57

(3008295) Osmolality of Serum or Plasma

479

1136

2.45

63.26

1.5

1.7

283.2

283.9

mosm/kgh2o

0.24

393

906

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

148

152

5.64

62.67

4.0

3.6

1.2

mmol/l

0.71

141

144

(3033799) Differential panel - Peritoneal fluid

162

187

5.02

61.20

2.1

1.5

—

(3049717) Cytology report of Urine Cyto stain

1074

3519

1.78

61.02

2.3

2.4

—

(40768441) Liver Pathology biopsy report

449

1065

2.45

59.32

1.7

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

995

3223

1.80

58.70

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1648

6125

1.58

58.33

1.7

1.6

10.2

1.3

iu/ml

0.44

339

1191

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

394

884

2.59

58.21

1.7

2.1

146.1

113.9

13.02

373

838

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3276

13962

1.38

58.10

2.4

2.3

21.3

21.6

au/ml

0.04

188

1164

(3048689) Calprotectin [Mass/mass] in Stool

6009

27962

1.28

58.02

2.5

2.6

130.4

116.3

ug/g

2.22

4874

22093

(3000093) Morphology [Interpretation] in Blood Narrative

447

1070

2.43

57.95

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1188

4075

1.70

57.59

1.5

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

579

1559

2.16

57.50

3.7

3.4

27.2

26.9

mu/l

0.07

559

1464

(1175426) CD3 cells/100 lymphocytes in Blood

540

1413

2.22

57.43

2.2

2.3

72.4

73.8

1.00

524

1376

(21491868) Cryoglobulin [Mass/volume] in Serum

259

459

3.27

57.34

1.2

0.1

0.4

g/l

1.39

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

14.56

57.15

11.9

2.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

535

1399

2.22

56.99

2.1

2.3

12.3

12.8

0.35

288

781

(3017704) Immunofixation for Urine

219

352

3.61

55.84

1.6

1.8

—

(44806071)

150

178

4.88

55.11

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

736

2211

1.94

54.69

1.3

1.2

56.7

48.1

u/ml

0.32

139

(3002256) Pathology report gross observation

4980

22784

1.30

54.56

1.3

1.2

—

(3019174) dRVVT (LA screen)

118

110

6.21

54.54

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

13.43

54.41

1.3

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3023

12852

1.38

54.27

1.3

45.5

49.0

au/ml

0.29

113

553

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1159

4028

1.68

53.54

1.3

1.2

41.4

38.9

u/ml

0.19

129

331

(3044009) aPTT.lupus sensitive (LA screen)

121

119

5.88

53.37

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6603

31357

1.25

53.36

3.4

21.7

20.9

3.37

2474

12597

(3035880) pH of Pleural fluid

173

240

4.17

53.34

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5038

36050

0.78

52.78

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

123

125

5.69

52.66

4.0

3.2

—

(3000330) Specific gravity of Urine by Test strip

1683

6435

1.53

52.52

3.5

2.4

—

(3025315) Body weight

10.38

52.39

3.9

1.6

—

(4146454)

399

952

2.43

52.14

2.9

2.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

986

3305

1.74

51.87

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

466

1197

2.26

51.80

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

328

718

2.65

50.88

2.2

2.5

170.1

158.4

umol/l

0.17

146

367

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

972

9216

0.60

50.84

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

269

529

2.95

50.52

1.6

1.4

12.0

11.0

u/l

1.24

260

520

(3037692) Legionella sp identified in Specimen by Organism specific culture

201

328

3.55

50.25

1.5

1.4

—

(3044941) Cell count panel - Synovial fluid

634

1866

1.98

49.96

1.5

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

300

634

2.74

49.69

1.8

2.1

172.1

125.0

10.41

283

596

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

327

726

2.61

49.40

1.3

1.2

96.6

86.3

u/l

0.54

297

634

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

815

2619

1.81

49.37

1.1

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

657

1968

1.94

49.27

1.8

1.6

39.3

33.9

iu/ml

0.31

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

166

238

4.04

49.21

3.3

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

166

238

4.04

49.21

3.3

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

208

353

3.41

49.19

1.2

11.7

20.7

u/l

3.75

191

337

(3014148) Varicella zoster virus Ab [Titer] in Serum

949

3197

1.73

49.07

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1117

10153

0.63

48.77

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

364

859

2.46

48.70

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

671

2033

1.92

48.69

3.1

3.2

219.9

452.0

u/ml

0.42

649

1848

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

492

1329

2.15

48.55

1.1

292.8

286.8

mg/l

0.76

446

1215

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

151

203

4.31

48.38

1.9

1.4

—

(1002224) Polysomnography panel

2380

9908

1.41

48.14

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

680

2080

1.90

47.99

3.7

3.6

691.9

331.7

u/ml

0.45

629

1894

(3017732) Neutrophils [#/volume] in Blood

3038

13176

1.36

47.98

2.9

2.3

4.3

4.0

e9/l

6.84

2532

10890

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

488

1324

2.14

47.65

1.4

1.2

2.0

1.8

mmol/l

3.20

453

1229

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

317

709

2.59

47.24

1.3

1.2

21.7

18.3

u/l

0.62

285

608

(3003338) MCHC [Mass/volume]

33667

186166

1.20

47.16

21.6

10.3

333.1

333.7

g/l

27.91

33505

184720

(3045716) Anion gap in Serum or Plasma

209

368

3.29

46.84

3.5

2.2

9.6

9.2

mmol/l

0.50

158

266

(3016018) Differential panel - Cerebral spinal fluid

657

2003

1.91

46.83

1.7

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

543

1548

2.04

46.71

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

251

499

2.92

46.33

2.8

2.2

26.5

85.8

umol/l

4.74

(3035947) Staphylolysin Ab [Units/volume] in Serum

283

603

2.72

46.22

1.2

1.1

4.1

3.6

iu/ml

0.55

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

783

7641

0.58

45.90

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

515

1449

2.06

45.87

3.0

3.1

4.4

7.2

nmol/l

0.34

492

1410

(3045142) Bone marrow Pathology biopsy report

445

1190

2.17

45.05

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5196

24439

1.26

44.87

1.7

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

216

400

3.13

44.81

2.2

1.8

186.2

21.3

ug/min

2.61

(21494815) CD4 cells/100 lymphocytes in Specimen

563

1653

1.98

44.72

2.2

2.5

43.1

43.0

0.01

226

(3033923) Metanephrine [Moles/time] in 24 hour Urine

133

172

4.48

44.59

1.1

1.2

0.6

umol/24h

0.58

101

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

355

867

2.38

44.24

1.9

1.8

4.3

2.6

mg/l

6.79

342

825

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

347

846

2.38

43.41

2.5

3.2

102.2

94.3

nmol/l

0.18

335

832

(3002331) Protein [Mass/volume] in Peritoneal fluid

114

132

5.00

43.07

1.6

1.3

24.2

26.2

g/l

0.43

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

120

146

4.76

43.04

1.5

1.2

55.4

56.2

0.07

100

129

(3000492) Spirometry study

4360

20174

1.28

43.01

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

448

5026

0.51

42.78

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

237

478

2.87

42.73

1.7

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

237

478

2.87

42.73

1.7

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

354

878

2.34

42.68

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1719

6902

1.46

42.23

2.3

2.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

365

926

2.29

41.85

2.5

2.9

42.9

40.1

1.25

130

286

(21494434) Karyotype in Bone marrow

346

859

2.34

41.64

1.2

—

(3023410) Appearance of Cerebral spinal fluid

624

1946

1.86

41.60

1.9

1.7

—

(3022621) pH of Urine by Test strip

2457

10557

1.36

41.00

2.9

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

267

589

2.63

40.94

1.8

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.84

40.79

6.3

3.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

266

587

2.63

40.76

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

266

587

2.63

40.76

1.8

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

266

587

2.63

40.76

1.8

2.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

430

1189

2.10

40.12

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

342

862

2.30

39.82

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

468

1341

2.03

39.79

3.8

3.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

360

929

2.25

39.73

2.4

2.1

2.0

1.8

umol/l

1.87

341

873

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

281

647

2.52

39.64

1.1

92.0

95.5

0.92

144

273

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

431

1199

2.09

39.61

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

285

664

2.49

39.27

1.2

1.1

105.5

112.5

1.61

258

595

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

261

584

2.59

38.97

1.3

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

17.72

38.91

1.2

1.0

—

(3021788) Differential panel - Synovial fluid

711

2358

1.75

38.88

1.6

1.5

—

(3047189) Immunofixation for 24 hour Urine

169

293

3.34

38.86

1.7

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3937

28078

0.79

38.84

1.7

1.6

—

(4034850)

1335

5181

1.50

38.82

10.4

6.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

201

392

2.97

38.43

2.4

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1264

4861

1.52

38.37

1.9

2.0

10.7

22.6

iu/l

0.45

495

1986

(3009542) Hematocrit [Volume Fraction] of Blood

35798

199913

1.19

38.26

18.5

9.0

40.1

40.7

38.92

27962

164936

(1761482) Bacteria [#/volume] in Urine by Culture

782

2681

1.70

38.05

4.1

2.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

102

120

4.92

37.96

1.5

1.2

2.7

3.6

0.32

106

(3010503) CD19 cells [#/volume] in Blood

355

932

2.21

37.66

2.3

3.0

0.3

0.2

e9/l

0.31

350

920

(3006922) Hepatitis E virus Ab [Presence] in Serum

454

1314

2.01

37.60

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

406

1127

2.09

37.55

3.2

2.9

58.7

54.7

2.50

269

720

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

255

575

2.57

37.53

1.3

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

463

1352

1.99

37.43

2.3

2.9

0.2

e9/l

1.61

385

1137

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

315

790

2.31

37.13

1.7

1.5

6.0

5.3

u/l

0.27

167

388

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2610

19455

0.76

36.58

1.4

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

467

1380

1.96

36.54

2.3

2.9

515.6

529.5

e6/l

0.19

383

1141

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

287

695

2.39

36.53

2.6

53.0

50.1

umol/l

0.86

248

622

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

604

1945

1.80

36.46

1.1

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1378

5456

1.47

36.34

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

412

1171

2.04

35.86

1.6

1.5

31.7

38.3

2.66

265

720

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

350

933

2.18

35.83

4.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

797

2792

1.66

35.82

5.7

5.5

370.8

385.4

umol/l

1.71

702

2457

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

593

1913

1.80

35.60

2.4

21.6

20.7

nmol/l

1.12

571

1841

(3013727) Leukocytes other/100 leukocytes in Blood

179

342

3.03

35.44

3.8

2.9

52.3

49.4

0.88

174

331

(3045414) Leukocytes [Presence] in Urine

1797

7509

1.40

35.42

1.9

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

199

406

2.84

35.28

2.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

195

397

2.84

34.70

1.5

1.2

104.6

104.3

0.03

185

371

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

326

856

2.21

34.62

1.4

1.2

71.0

75.1

0.31

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

483

1472

1.90

34.60

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

482

1468

1.91

34.60

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

218

473

2.67

34.59

3.8

2.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

482

1469

1.90

34.53

1.2

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

48.19

34.45

3.6

2.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

266

640

2.41

34.36

1.2

1.1

89.6

99.0

2.69

137

273

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

343

926

2.15

34.08

1.5

1.4

6.2

5.5

u/l

0.72

293

787

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1479

6025

1.43

33.63

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

319

841

2.20

33.58

1.8

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

485

1496

1.88

33.54

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

484

1493

1.88

33.47

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

468

1428

1.90

33.43

1.1

53.7

73.6

u/ml

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

484

1494

1.88

33.40

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1340

5367

1.46

33.33

1.2

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

114

4.72

33.19

1.5

1.2

31.6

27.4

0.51

105

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

312

819

2.21

33.19

2.5

2.2

27.7

28.5

umol/l

0.53

307

789

(3008116) Ketones [Moles/volume] in Urine by Test strip

136

227

3.47

33.12

1.5

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

1343

5394

1.45

32.93

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

185

377

2.84

32.90

1.2

1.1

81.8

93.3

1.52

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1325

5320

1.45

32.54

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

563

1841

1.78

32.38

1.2

1.1

36.6

41.6

mg/l

1.70

480

1532

(3006245) CD3-CD19+ cells/100 cells in Blood

320

864

2.15

31.82

2.4

2.6

13.5

10.3

2.41

300

831

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1841

7865

1.37

31.74

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1586

6612

1.40

31.67

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

501

1592

1.83

31.64

1.7

1.6

56.5

49.9

2.76

313

1017

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

547

1789

1.78

31.46

1.1

240.2

240.4

mg/l

0.01

486

1572

(3010144) Erythrocytes [#/volume] in Synovial fluid

383

1114

1.99

31.40

1.5

1.4

86806.8

39059.0

e6/l

0.89

274

752

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1975

8552

1.35

31.23

1.1

15.8

12.8

u/ml

0.10

112

(40768443) Skin Pathology biopsy report

1685

7125

1.38

30.94

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

182

381

2.77

30.90

1.2

1.1

71.9

77.7

0.48

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

297

789

2.18

30.75

3.5

1.4

46.5

322.5

ug/l

1.28

282

750

(3045462) Protein/Creatinine [Ratio] in Urine

139

252

3.19

30.00

6.5

5.3

127.2

46.5

g/mol

0.74

130

235

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

530

1750

1.76

29.55

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

150

289

3.00

29.40

1.3

1.1

—

(4027681)

458

1449

1.83

29.37

1.3

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

222

533

2.41

28.91

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

301

831

2.10

28.38

2.2

2.5

27.1

28.7

1.12

288

802

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

117

197

3.44

28.22

1.1

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

132

4.07

28.13

2.4

1.9

179.6

168.0

ug/g

0.25

114

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

513

1705

1.75

28.00

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.91

27.94

1.0

27.3

25.6

u/l

0.12

(21494814) CD8 cells/100 lymphocytes in Specimen

239

604

2.29

27.85

2.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

525

2.39

27.82

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3245

15231

1.25

27.79

2.4

2.1

11.9

13.0

nmol/l

11.83

2914

13833

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

200

466

2.48

27.73

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

200

466

2.48

27.73

1.3

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

249

642

2.25

27.73

1.6

6.9

5.8

mmol/24h

0.53

(3022689) Creatine [Moles/volume] in Urine

164

345

2.75

27.66

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1149

4642

1.44

27.35

2.0

1.8

188.2

202.9

pmol/l

4.66

1089

4475

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

264

702

2.18

27.34

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

3728

17796

1.23

27.32

1.2

—

(3003129) Base excess in Capillary blood by calculation

115

196

3.39

27.27

1.5

1.6

0.5

0.8

mmol/l

0.37

105

189

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

353

1051

1.95

27.19

1.8

1.6

1826224.7

1691389.7

iu/ml

0.06

(3009871) Measles virus Ab [Titer] in Serum

258

683

2.19

27.01

1.6

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3520

16722

1.23

26.99

1.2

144.5

150.2

iu/ml

0.31

1340

6531

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

359

1090

1.91

26.16

2.0

2.1

22.4

25.4

ug/l

0.42

351

1075

(3020717) Zinc [Moles/volume] in Serum or Plasma

339

1011

1.94

26.02

1.7

1.6

21.2

27.4

umol/l

3.42

326

964

(3004616) Nuclear Ab [Presence] in Serum

592

2091

1.64

25.92

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

128

3.98

25.86

2.5

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

197

472

2.42

25.83

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

197

472

2.42

25.83

2.0

2.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

226

579

2.26

25.58

1.4

14.8

13.4

pmol/l

1.92

195

491

(40758047) Lysozyme [Mass/volume] in Pleural fluid

7.55

25.52

1.0

1.1

12.3

11.6

mg/l

0.10

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6602

43308

0.86

25.52

2.1

2.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

245

651

2.18

25.46

1.2

1.1

84.0

71.8

u/l

1.15

197

546

(3001186) Copper [Moles/volume] in Serum or Plasma

196

473

2.40

25.32

1.4

17.3

16.6

umol/l

0.91

172

422

(40762365) Oxygen content in Arterial blood by calculation

4.50

25.21

2.1

4.2

15.5

14.9

ml/dl

0.70

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

243

649

2.17

24.95

1.2

1.1

20.4

16.1

u/l

0.93

183

522

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

198

484

2.37

24.90

2.0

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4052

19682

1.21

24.86

4.4

3.3

31.0

31.5

2.65

3147

13580

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

245

658

2.16

24.82

1.1

—

(3024263) Appearance of Synovial fluid

231

606

2.21

24.77

1.7

2.0

—

(4198724)

435

1430

1.76

24.72

2.8

2.4

—

(3000012) Reticulocyte production index

205

512

2.32

24.60

1.7

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

314

935

1.95

24.25

1.1

3.9

5.5

nmol/l

0.22

176

(3013139) Helicobacter pylori Ag [Presence] in Stool

2761

12919

1.25

24.22

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3708

25386

0.83

23.75

2.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

425

1407

1.75

23.61

2.4

2.9

753.0

789.1

e6/l

0.38

157

539

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

137

286

2.77

23.52

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1705

7539

1.32

23.37

1.6

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2292

10558

1.27

22.97

3.2

2.7

41.7

35.1

u/ml

1.01

2216

10225

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

374

1204

1.80

22.82

1.1

u/l

0.03

176

531

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

113

215

3.04

22.73

1.5

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

156

3.45

22.65

1.3

1.2

3.1

4.2

mmol/l

1.64

145

(3028433) Virus identified in Specimen by Culture

195

495

2.28

22.62

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

273

794

1.99

22.56

1.3

1.2

260.5

414.6

u/l

1.43

249

758

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

249

712

2.03

21.58

1.2

0.3

g/l

1.65

200

564

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

528

1919

1.60

20.74

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

132

290

2.63

20.69

2.8

2.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

518

1879

1.60

20.52

1.5

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.26

20.51

1.6

1.2

10.9

13.5

0.22

(3005988) Vibrio sp identified in Specimen by Organism specific culture

513

1859

1.60

20.41

1.5

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

231

657

2.04

20.34

1.3

1.2

112.0

109.0

0.93

209

593

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

125

3.61

20.30

2.8

2.9

1.2

0.9

mg/l

0.41

(3025468) Yersinia sp identified in Specimen by Organism specific culture

511

1854

1.60

20.23

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

516

1877

1.59

20.21

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

512

1859

1.60

20.21

1.5

1.4

—

(3024316) Viscosity of Plasma

5.91

20.15

1.2

1.8

1.3

1.8

mpas

3.34

(3023323) Follitropin [Units/volume] in Serum or Plasma

3166

15315

1.21

20.13

1.4

1.3

24.7

25.4

iu/l

0.50

2695

13200

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4725

23688

1.17

19.97

2.5

2.6

0.7

ug/l

1.55

2719

12948

(3026389) Candida sp identified in Specimen by Organism specific culture

666

2576

1.50

19.88

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

162

3.21

19.82

1.2

1.1

4.3

2.4

pmol/l

0.77

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.78

19.76

1.3

797.1

132.1

u/l

0.49

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

954

3958

1.40

19.71

1.3

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

134

305

2.54

19.65

1.7

1.8

36.4

u/l

0.00

124

261

(3013166) Neutrophils/100 leukocytes in Synovial fluid

142

334

2.46

19.49

1.5

1.3

49.2

46.0

0.41

122

287

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

373

2.37

19.48

2.8

2.4

—

(40757373) Influenza virus identified in Isolate

100

195

2.97

19.40

1.7

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

244

721

1.96

19.39

2.3

2.5

195.6

250.8

e6/l

1.42

137

414

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6031

39139

0.87

19.36

2.0

2.1

—

(3014891) Appearance of Pleural fluid

6.23

19.24

1.7

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

405

1404

1.67

19.20

1.6

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

111

232

2.77

19.12

2.0

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

165

420

2.27

19.11

1.4

1.3

123.3

121.0

nmol/l

0.06

133

307

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1229

5344

1.34

18.96

1.4

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

322

1051

1.77

18.89

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

322

1052

1.77

18.83

1.1

1496.0

1497.8

miu/ml

0.01

322

1052

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

108

226

2.76

18.57

1.4

1.5

64.7

58.0

ng/l

0.10

122

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

641

5354

0.69

18.48

1.3

3.1

3.5

ug/l

0.70

553

4957

(3029075) Extractable nuclear Ab panel - Serum

200

560

2.07

18.41

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

101

3.78

18.30

1.1

1.0

2.1

1.4

umol/24h

2.19

101

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

412

1454

1.64

18.28

1.3

0.9

1.4

u/ml

0.58

197

522

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

366

1252

1.69

18.26

1.2

56.3

42.8

u/ml

0.41

(3001686) Cold agglutinin [Titer] in Serum or Plasma

102

209

2.82

18.22

1.3

1.5

40.4

213.6

titre

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

109

232

2.72

18.19

1.3

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

365

1251

1.69

18.08

1.2

73.5

61.9

u/ml

0.28

(3008536) Aspergillus sp Ab [Presence] in Serum

114

250

2.64

18.01

2.6

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2940

20069

0.83

17.98

1.8

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

186

513

2.10

17.81

1.6

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

217

636

1.97

17.69

1.4

21.4

19.2

u/ml

0.34

111

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

546

2078

1.52

17.64

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

105

223

2.72

17.61

1.3

1.1

193.4

34.2

mg/l

1.21

166

(3009214) Lutropin [Units/volume] in Serum or Plasma

1830

8471

1.26

17.61

1.5

1.4

9.8

9.0

u/l

1.59

1505

6913

(3038026) Centromere Ab [Units/volume] in Serum

371

1287

1.67

17.60

1.2

1.3

40.1

56.2

u/ml

0.36

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

252

784

1.86

17.28

2.5

2.9

1.4

1.2

ug/l

0.64

229

740

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

147

373

2.28

17.21

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

131

316

2.40

17.13

1.1

—

(3045424) Erythrocytes [Presence] in Urine

718

2907

1.43

17.07

1.6

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

378

1329

1.65

17.06

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1327

5926

1.30

17.00

3.5

3.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

220

659

1.93

16.89

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

5.50

16.83

1.4

66.2

61.2

0.30

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.99

16.82

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

349

1208

1.67

16.72

1.2

12.5

8.1

u/ml

0.23

(1761868) Lipid panel - Serum or Plasma

15297

83102

1.10

16.69

2.9

2.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

117

3.41

16.67

1.4

1.3

28.6

27.3

0.10

105

(3006442) Creatine [Moles/volume] in Serum or Plasma

344

1198

1.66

16.13

1.6

1.3

68.4

69.5

umol/l

0.14

127

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

306

2893

0.61

16.01

1.4

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

15.79

2.7

0.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.38

15.66

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

160

439

2.11

15.60

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

153

2.98

15.60

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

333

1161

1.66

15.57

1.4

1.5

7.1

7.0

ug/l

0.01

297

1048

(3034891) Synovial lining cells/100 cells in Synovial fluid

210

638

1.90

15.53

1.6

1.4

3.4

4.8

0.69

148

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

378

1365

1.60

15.40

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

833

3528

1.37

15.32

2.2

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

187

2.75

15.29

2.2

1.8

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

8.34

15.18

1.2

1.1

264.4

269.9

pmol/l

0.02

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

141

372

2.19

15.15

4.7

4.1

—

(4281824)

439

1649

1.54

15.14

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

433

2.10

15.13

1.1

—

(3042517) Benzodiazepines panel - Urine

142

377

2.18

15.03

3.1

3.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

388

1419

1.58

15.02

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

135

3.08

14.99

2.7

3.5

41.8

44.1

umol/l

0.31

112

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.57

14.97

1.2

1.8

2.3

mmol/l

1.04

(3020393) Adenovirus Ag [Presence] in Stool

107

251

2.47

14.90

1.9

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

175

508

1.99

14.75

1.3

1.2

14.1

13.9

0.02

(40768795) Lymph node Pathology biopsy report

409

1528

1.55

14.47

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

147

404

2.10

14.32

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

383

1415

1.57

14.23

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.88

14.15

1.3

1.2

1.3

3.4

mmol/l

0.76

(3052592) Norovirus Ag [Presence] in Stool

179

2.71

14.10

1.4

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

283

975

1.68

13.90

2.1

1.7

1.4

2.3

u/field

3.46

150

495

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

194

597

1.88

13.87

1.3

1.2

836.3

252.1

titre

—

(40765096) Chromosome analysis panel by Banding

125

326

2.22

13.85

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

803

3439

1.35

13.82

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

188

575

1.89

13.70

1.3

1.2

46.4

76.3

titre

0.67

(3043410) Blood group antigens tested for on Red Blood Cells

138

377

2.12

13.67

1.7

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

208

2.53

13.40

1.5

1.7

89479.1

468611.3

nmol/l

1.37

172

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

109

272

2.32

13.37

3.2

4.8

42.0

69.2

u/l

0.96

103

(40761539) Cells [Type] in Urine sediment by Light microscopy

117

302

2.24

13.30

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

107

269

2.30

12.93

2.7

2.8

0.8

1.7

mmol/l

3.20

205

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

219

2.46

12.92

2.8

2.9

—

(3013637) Mi-2 Ab [Presence] in Serum

123

329

2.16

12.87

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

123

329

2.16

12.87

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

123

329

2.16

12.87

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

123

329

2.16

12.87

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

231

769

1.74

12.87

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

216

705

1.77

12.87

1.1

170.2

303.1

ng/l

0.75

152

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

229

761

1.74

12.84

1.8

1.5

2.3

2.4

u/field

0.06

172

570

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

136

2.89

12.81

1.5

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

174

532

1.89

12.73

2.8

28.0

27.6

umol/l

0.14

121

409

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

214

2.46

12.68

1.6

1.7

1.8

mg/l

0.07

145

(3021162) Amylase [Enzymatic activity/volume] in Specimen

180

2.60

12.63

3.3

2.7

3607.5

1775.8

u/l

0.58

160

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.52

12.49

1.9

2.0

38.2

50.6

umol/l

1.39

(3008898) HLA-B27 [Presence]

1890

9114

1.21

12.41

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

780

3383

1.34

12.41

3.7

2.6

22.1

25.1

mg/l

1.58

519

1966

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

377

1435

1.52

12.35

2.0

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1518

7166

1.23

12.33

1.9

1.7

36.5

40.6

nmol/l

8.32

1483

7047

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

148

433

1.98

12.31

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2488

12306

1.18

12.28

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

874

3863

1.31

12.20

1.1

12.3

11.5

au/ml

0.11

305

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

3.85

12.07

1.1

1.2

0.0

0.7

mg/l

0.50

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

666

2834

1.36

12.01

2.0

1.8

3416.8

4772.1

titre

0.41

149

(3020961) Endomysium IgA Ab [Titer] in Serum

2321

11441

1.18

11.94

1.1

139.9

210.9

titre

0.71

329

(3003327) Ova and parasites identified in Stool by Light microscopy

1635

7810

1.22

11.85

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

236

2.33

11.83

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1004

4540

1.28

11.82

1.4

1.3

24.9

23.2

u/l

0.85

834

3770

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

0.7

1.0

mg/l

0.55

149

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

2.2

2.5

mg/l

0.17

145

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

2.0

1.7

mg/l

0.28

155

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

2.6

2.8

mg/l

0.09

153

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

1.1

1.3

mg/l

0.18

138

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

1.4

1.9

mg/l

0.44

132

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

2.2

3.0

mg/l

0.72

151

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

4.6

4.1

mg/l

0.22

137

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

211

2.41

11.82

1.6

1.7

2.0

2.1

mg/l

0.07

155

(3018133) Calcium [Moles/volume] in Urine

128

361

2.05

11.77

2.7

2.6

2.5

2.8

mmol/l

0.76

116

332

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

359

3047

0.68

11.48

1.5

1.6

8.0

7.5

mmol/l

2.89

226

1830

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

187

606

1.79

11.47

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1977

9650

1.19

11.40

1.3

210.7

228.2

miu/ml

1.29

828

4882

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

147

442

1.92

11.36

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.14

11.02

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

113

313

2.09

10.92

1.0

76.3

78.9

ug/l

0.25

271

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

347

1335

1.50

10.89

2.7

3.0

27.8

26.1

ug/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.38

10.87

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.10

10.85

1.2

1.1

—

(4015189)

241

2.23

10.58

2.4

2.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

244

2201

0.64

10.58

1.3

1.4

29.0

32.0

nmol/l

1.05

209

2036

(3044416) Complement C4 [Mass/volume] in Pleural fluid

6.04

10.58

1.0

1.1

0.1

g/l

0.10

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1072

4963

1.25

10.45

1.5

1.4

138.4

84.6

pmol/l

2.30

1048

4842

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

111

311

2.06

10.44

1.4

1.3

38.7

43.0

0.52

214

(44786800) Granulocytes/100 leukocytes in Body fluid

4.14

10.42

1.3

25.3

33.6

0.49

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

190

2.37

10.20

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.69

10.10

1.6

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

191

2.36

10.09

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

177

2.42

10.06

1.4

1.2

42.8

65.4

3.16

(3047007) Chlamydophila sp Ab [Presence] in Serum

790

3540

1.29

10.06

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

147

463

1.84

9.95

1.7

1.6

8.6

8.5

ug/l

0.06

147

463

(44806420)

172

2.42

9.83

2.1

2.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.74

9.76

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

191

2.33

9.71

1.3

1.5

—

(3006270) Folate [Moles/volume] in Blood

311

1201

1.50

9.65

1.1

402.8

408.1

nmol/l

0.17

281

1122

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

356

1.93

9.42

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

151

489

1.79

9.39

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

220

2.21

9.38

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

198

2.28

9.36

1.5

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2255

11313

1.16

9.34

1.7

1.6

305.6

311.0

mu/l

0.28

2030

10169

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

159

2.44

9.29

1.1

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.03

9.19

2.1

1.3

20.7

23.2

0.09

(3011544) Albumin [Mass/volume] in Pleural fluid

4.26

9.14

1.0

1.1

16.6

22.0

g/l

1.82

(3013466) aPTT in Blood by Coagulation assay

119

2.67

9.14

1.1

35.8

36.4

0.37

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

119

2.67

9.14

2.9

3.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

153

1484

0.59

9.14

1.5

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

103

2.81

9.07

1.2

1.3

1.2

2.4

ml/s/173m2

1.00

(3023511) Choriogonadotropin [Units/volume] in Urine

1482

7211

1.19

8.93

1.4

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

210

2.20

8.91

1.8

1.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.78

8.90

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.17

8.85

1.1

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8354

45210

1.08

8.73

1.8

1.7

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.03

8.70

1.2

1.3

32.8

16.1

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.08

8.68

1.1

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.83

8.67

1.4

1.5

11.7

9.5

pmol/l

0.29

(3007463) Buprenorphine [Presence] in Urine

127

2.55

8.54

7.6

8.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

141

2.46

8.53

1.1

1.2

65.1

273.5

ug/l

1.28

(3001729) Color of Synovial fluid

3.13

8.49

1.9

1.5

—

(3020491) Glucose [Moles/volume] in Blood

327

1311

1.44

8.48

1.8

1.5

6.9

6.0

mmol/l

5.41

247

1014

(3050794) Legionella sp Ab [Presence] in Serum

118

2.60

8.38

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

284

1112

1.48

8.32

6.5

7.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

263

2.02

8.32

1.2

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

483

1.74

8.26

1.5

1.8

—

463.8

iu/ml

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.89

8.06

1.1

3.0

3.8

u/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

199

726

1.59

8.05

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

176

2.23

7.88

3.3

3.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

246

2.02

7.79

2.1

1.8

40.4

52.7

pmol/l

0.27

210

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.36

7.77

2.1

1.4

52.6

54.3

0.07

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

186

676

1.59

7.67

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

413

1757

1.36

7.66

14.1

13.8

863.2

1125.4

nmol/l

0.41

398

1706

(4024509)

310

1256

1.43

7.66

1.6

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

160

561

1.65

7.61

2.6

3.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

632

4595

0.79

7.36

1.6

1.5

—

(3048879) Bone marrow aspiration report

244

1.99

7.33

2.1

2.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

159

563

1.63

7.31

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.78

7.24

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

302

1.88

7.23

1.3

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

110

2.52

7.23

1.2

1.3

555.3

81.0

mg/24h

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

104

329

1.83

7.09

1.2

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

204

2.07

7.07

4.7

2.4

10.4

5.8

0.82

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

201

2.07

7.00

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

9695

53142

1.07

6.95

1.7

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

2.55

6.94

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.98

6.90

1.1

1.0

0.1

u/ml

0.03

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

375

1601

1.36

6.86

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

191

2.09

6.86

2.0

2.2

7.0

7.1

mmol/l

0.07

110

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

382

1638

1.35

6.80

2.4

1.7

24.7

26.4

mg/l

0.26

106

434

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

377

1615

1.35

6.76

12.5

11.8

0.6

mmol/l

0.42

344

1496

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

132

2.32

6.75

1.1

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

423

1844

1.33

6.75

20.5

19.3

3165.2

1927.3

nmol/l

0.32

410

1765

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

446

1961

1.32

6.71

4.6

62.9

120.3

u/ml

2.21

138

644

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.22

6.66

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

233

1.96

6.65

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

168

2.13

6.52

1.1

—

(3025577) Chromium [Mass/volume] in Blood

148

533

1.61

6.42

2.0

2.1

2.3

2.5

ug/l

0.33

124

461

(3026470) Cobalt [Mass/volume] in Blood

151

547

1.60

6.40

1.9

2.1

3.5

3.2

ug/l

0.21

133

491

(3035320) C reactive protein [Mass/volume] in Body fluid

293

1222

1.39

6.24

2.9

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

2.07

6.24

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.89

6.21

2.0

1.5

0.3

0.4

0.33

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

591

2734

1.25

6.02

3.8

3.5

30.9

34.4

u/ml

0.33

574

2637

(3013247) Albumin in CSF/Albumin in Serum or Plasma

151

556

1.57

6.01

1.1

6.3

mg/g

0.01

143

529

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

263

1.85

5.99

1.6

1.5

0.4

ug/l

0.13

180

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

159

2.11

5.96

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

171

2.06

5.93

1.1

1.3

46.2

46.9

mg/l

0.06

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.55

5.93

1.5

1.3

15.3

20.3

pmol/l

0.63

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

156

581

1.55

5.92

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.94

5.81

1.1

1.0

0.1

0.0

u/ml

0.74

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

234

1.88

5.72

1.1

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.92

5.70

3.6

2.4

1035.8

2334.3

umol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

306

1.76

5.68

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2745

14410

1.11

5.59

2.4

2.3

5557.8

6362.3

u/l

0.63

913

5965

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.41

5.58

1.1

22.0

22.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

157

2.06

5.48

1.2

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

337

1.70

5.40

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.53

5.39

1.8

1.4

16.4

13.7

0.24

(3012403) Metanephrines [Moles/time] in 24 hour Urine

5.78

5.33

1.0

36.8

21.3

umol/24h

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1352

6824

1.15

5.31

1.1

6.7

4.7

u/ml

0.70

178

1106

(3000285) Sodium [Moles/volume] in Blood

117

2.22

5.29

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

6.35

5.28

1.2

1.5

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.71

5.26

1.1

1.0

0.2

g/l

0.80

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.39

5.23

1.8

1.3

40.8

23.5

1.57

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.50

5.21

1.1

1.2

1.1

1.2

u/field

0.25

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.40

5.01

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

2.03

5.01

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.66

4.94

1.1

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.78

4.88

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

299

1.70

4.88

1.3

39.6

40.9

g/l

0.37

166

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

1.95

4.85

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

107

2.21

4.81

2.0

2.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.29

4.80

1.2

1.0

17.8

8.2

u/l

0.71

(3001019) Free T4 and TSH panel - Serum or Plasma

2575

16232

0.91

4.70

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.64

4.67

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

3.64

4.67

2.1

1.4

355.1

335.3

umol/l

0.04

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

740

3603

1.19

4.65

1.7

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

459

2132

1.25

4.63

1.3

1.4

11.4

mmol/l

0.02

140

324

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

186

759

1.42

4.62

1.0

39.0

42.9

ng/l

0.64

121

568

(3036048) Francisella tularensis Ab [Titer] in Serum

120

448

1.55

4.61

1.2

200.0

655.0

titre

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.29

4.56

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

310

1.66

4.54

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5328

32587

0.94

4.51

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

185

758

1.41

4.51

1.0

774.5

751.4

ng/l

0.26

124

561

(3022229) Phosphate [Moles/volume] in Urine

174

1.89

4.49

2.1

2.8

17.1

21.3

mmol/l

1.15

159

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

184

755

1.41

4.45

1.0

273.9

329.3

ng/l

2.01

123

579

(3009015) Lactate [Moles/volume] in Synovial fluid

105

2.15

4.29

1.3

1.2

5.6

6.0

mmol/l

0.21

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.04

4.29

2.1

1.4

253.0

270.7

nmol/l

0.05

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.49

4.25

1.0

24.1

16.2

iu/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1827

9541

1.11

4.20

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

153

1243

0.71

4.16

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

111

2.08

4.11

2.5

3.4

3.8

64.6

pmol/l

1.90

(3051101) Glucose [Moles/volume] in Cord blood

147

1.93

4.09

6.0

5.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.62

4.01

1.5

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

760

0.64

4.01

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

136

1.95

4.01

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

234

1018

1.33

3.99

2.4

2.9

136.2

130.8

au/ml

0.06

138

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

331

1.59

3.97

1.6

1.8

5.3

3.6

ug/l

0.22

199

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

676

3317

1.18

3.95

1.3

1.4

7.2

6.7

mmol/l

3.98

517

2352

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.44

3.95

2.6

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

243

1.69

3.92

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

492

1.47

3.83

1.2

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.34

3.79

1.7

1.3

1.4

2.0

0.24

(3028679) Herpes simplex virus Ab [Presence] in Serum

314

1433

1.27

3.77

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

341

1573

1.25

3.75

1.4

1.3

4.6

5.6

umol/l

6.20

316

1453

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

285

2084

0.79

3.73

2.0

1.8

—

(44813793)

357

1657

1.25

3.72

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

100

2.08

3.72

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

367

1.53

3.61

1.6

2.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

277

1.61

3.55

3.1

3.4

—

(36303858) Crystals [Presence] in Urine

3.58

3.53

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.46

3.46

13.4

8.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.46

3.46

1.2

1.3

1.5

1.4

u/field

0.19

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.58

3.46

2.0

1.4

294.3

271.8

nmol/l

0.07

(3019897) Erythrocyte distribution width [Ratio] by Automated count

802

4036

1.15

3.44

2.9

2.1

13.2

13.1

5.40

795

3979

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.81

3.44

1.2

1.0

104.0

104.8

nmol/24h

0.01

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

132

1.88

3.42

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

251

1131

1.28

3.39

2.8

3.5

7.5

8.4

mg/l

1.42

196

914

(3002621) Streptococcal DNAse B [Units/volume] in Serum

184

1.73

3.34

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

130

1.87

3.27

1.3

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.57

3.27

1.2

—

mmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

112

447

1.45

3.27

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

212

1.66

3.25

1.6

1.3

161.0

157.4

titre

0.01

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

239

1079

1.28

3.20

1.3

1.4

72.9

72.7

0.07

228

1028

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

122

497

1.42

3.20

1.4

1.6

0.2

0.3

nmol/l

2.51

367

(3049242) von Willebrand panel - Platelet poor plasma

2.67

3.16

1.4

1.5

—

(4212803)

2.21

3.14

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.73

3.11

2.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.09

3.09

2.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

275

0.48

3.09

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

146

1.78

3.06

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.35

3.05

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

233

1057

1.27

3.03

1.4

481.9

556.3

mu/l

0.76

222

1006

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.99

2.98

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

122

1.85

2.97

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

125

519

1.39

2.97

1.3

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

156

1.74

2.97

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

278

1292

1.24

2.96

1.2

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

125

520

1.39

2.94

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method

1848

9840

1.09

2.94

4.0

3.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

247

1.57

2.87

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.95

2.85

1.4

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.58

2.84

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

682

0.69

2.83

1.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

239

1.57

2.82

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

5.13

2.81

3.9

7.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

124

520

1.38

2.80

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.29

2.77

5.6

5.5

—

(3006598) pH of Arterial cord blood

324

0.55

2.76

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

380

1838

1.20

2.76

2.5

1.9

—

(3004959) Base excess in Arterial cord blood by calculation

322

0.56

2.71

1.0

0.1

-2.4

mmol/l

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

199

900

1.28

2.70

2.2

2.4

157.7

151.6

nmol/l

0.27

177

782

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.79

2.68

1.4

1.3

112.9

61.5

e6/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

280

1.51

2.66

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2398

12956

1.07

2.65

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

618

4070

0.87

2.64

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7277

43515

0.96

2.62

1.5

—

(4211845)

190

860

1.28

2.58

2.7

2.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.18

2.57

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

938

4878

1.11

2.49

1.8

1.7

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.31

2.45

1.2

1.3

1.4

1.3

u/field

0.07

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.18

2.40

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.34

2.37

1.4

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.09

2.30

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.95

2.29

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.77

2.29

1.0

1.1

—

(3007733) Chloride [Moles/volume] in Urine

2.21

2.24

2.0

2.1

96.3

89.4

mmol/l

0.20

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

130

1.69

2.24

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

201

934

1.24

2.24

2.0

2.1

8.1

9.9

mg/l

4.82

167

748

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

135

1006

0.77

2.23

6.2

6.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.41

2.23

1.5

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.95

2.21

1.5

1.3

482.5

533.3

nmol/l

0.17

(40768800) Prostate Pathology biopsy report

346

2340

0.85

2.20

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

242

1151

1.22

2.18

1.2

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

295

1430

1.19

2.18

4.1

3.9

45.6

44.1

u/ml

0.05

295

1421

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.67

2.15

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.67

2.15

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.67

2.15

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.67

2.15

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.67

2.15

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.67

2.15

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.79

2.15

4.2

5.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

136

1006

0.78

2.14

3.1

3.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

300

1.42

2.12

8.1

7.5

—

(3025130) Human papilloma virus identified in Specimen

645

4167

0.89

2.10

1.7

—

(42870560) Thyrotropin [Units/volume] in Cord blood

369

0.64

2.10

1.0

9.6

8.7

mu/l

0.42

308

(3034614) HLA Ag [Interpretation]

2.12

2.06

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

105

457

1.33

1.98

1.2

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

4.33

1.97

1.2

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

4.33

1.97

1.2

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

323

2173

0.86

1.97

1.4

1.3

143.6

117.6

pmol/l

0.12

128

587

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.67

1.97

5.9

6.9

—

(3009992) Blasts/100 cells in Bone marrow

3.67

1.97

2.6

1.9

2.3

13.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

271

1.43

1.96

10.1

4.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

359

1.37

1.95

1.2

1.1

0.0

0.2

u/ml

1.15

215

(3034274) Bile acid [Moles/volume] in Serum --fasting

719

4594

0.90

1.94

2.7

2.3

7.8

6.0

umol/l

1.44

525

3333

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.31

1.94

7.9

5.1

3.7

10.6

mg/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.31

1.94

1.6

2.2

3.6

2.4

mu/l

0.28

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

927

4896

1.10

1.90

1.4

1.5

0.4

nmol/l

0.06

714

3971

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.54

1.83

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.85

1.81

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2074

11318

1.06

1.79

3.0

2.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

214

1.46

1.79

1.7

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

198

1374

0.83

1.78

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

208

999

1.20

1.77

7.9

6.5

408.2

4092.9

u/ml

0.70

224

(3033942) Copper [Moles/time] in 24 hour Urine

104

1.67

1.75

1.1

1.3

0.6

1.0

umol/24h

0.44

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

325

1624

1.16

1.73

1.1

11.0

7.7

iu/ml

0.96

448

(3027570) Oxalate [Moles/time] in 24 hour Urine

128

1.58

1.67

1.6

1.4

311.5

307.3

umol/24h

0.05

128

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

182

869

1.21

1.66

1.3

1.1

—

(3015183) Erythrocyte sedimentation rate

283

1405

1.16

1.66

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.89

1.66

2.4

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.96

1.64

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9982

56394

1.03

1.64

2.1

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

209

1.44

1.63

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

150

1058

0.82

1.62

3.2

3.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.81

1.62

1.7

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

403

1.30

1.59

2.4

2.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

158

748

1.22

1.59

1.7

1.8

153.3

157.7

au/ml

0.03

(3001556) Androgen free Index in Serum or Plasma

363

1.32

1.58

1.5

1.2

—

(3006462) Nitrate [Presence] in Urine

163

775

1.22

1.57

2.8

2.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.64

1.52

1.9

2.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

1.52

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1692

10327

0.94

1.50

2.0

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1800

9848

1.06

1.48

2.3

1.4

4.4

3.1

mg/l

2.63

1396

6419

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

257

1282

1.16

1.46

1.4

5.6

5.3

mmol/l

2.94

246

1220

(43055514) Macroprolactin [Presence] in Serum or Plasma

168

809

1.20

1.45

1.3

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.75

1.41

1.7

1.5

0.0

0.1

u/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

906

4855

1.08

1.41

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

177

1.44

1.41

1.1

0.1

2.1

u/ml

2.86

126

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

124

0.51

1.39

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.03

1.38

1.9

1.3

1.7

2.2

mmol/24h

0.65

(3041672) Baker's yeast Ab [Presence] in Serum

145

1.47

1.36

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.57

1.35

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.88

1.33

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.17

1.30

1.0

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

738

3941

1.08

1.28

1.2

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.81

1.27

1.1

1.0

0.2

1.7

u/ml

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.67

1.24

1.1

1.0

0.4

0.9

u/ml

0.59

(3003740) Influenza virus B Ag [Presence] in Specimen

901

4858

1.07

1.23

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.20

1.19

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

217

1092

1.15

1.16

1.1

9.0

12.1

u/ml

0.62

199

(3001218) Citrate [Mass/time] in 24 hour Urine

2.06

1.12

1.7

1.3

—

(3020650) Glucose [Presence] in Urine

122

589

1.20

1.10

1.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

313

1.27

1.09

1.0

0.2

0.3

u/ml

0.28

185

(3007456) Orange IgE Ab [Units/volume] in Serum

1.65

1.08

1.0

0.1

0.2

u/ml

0.56

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.73

1.06

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

1.61

1.06

1.0

—

(40763590) HLA-DQ beta [Type]

1.61

1.06

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

176

883

1.15

1.02

1.3

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.49

1.01

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

367

1926

1.10

1.01

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

227

1475

0.89

0.98

1.5

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.92

0.96

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

108

524

1.19

0.96

1.3

1.6

5.3

5.5

nmol/l

0.17

101

499

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.31

0.95

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

1.55

0.92

4.5

2.7

—

(40762887) Creatinine [Moles/volume] in Blood

1.92

0.89

1.3

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

271

1.26

0.89

1.1

—

(40760409) HLA-A [Type] by High resolution

1.55

0.89

1.0

—

(40760410) HLA-B [Type] by High resolution

1.55

0.89

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.73

0.87

1.2

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.79

0.78

1.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.79

0.78

1.0

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.73

0.77

1.1

1.0

111.4

138.8

mmol/24h

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.22

0.77

1.4

1.0

—

(3013862) HLA-DP [Type]

1.48

0.76

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

124

1.35

0.75

3.3

2.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.68

0.75

1.6

1.0

2.6

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

190

1.28

0.75

1.0

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.44

0.74

1.0

0.1

u/ml

0.02

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.60

0.73

1.1

1.3

195.1

260.1

nmol/l

0.76

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

226

1435

0.91

0.71

1.7

1.9

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

1.76

0.71

1.4

1.1

1.4

mg/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

116

585

1.15

0.70

2.4

2.1

157.4

102.6

ng/l

0.85

378

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

286

1.21

0.70

1.9

1.7

1.6

1.8

mg/l

0.28

239

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.53

0.70

1.2

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.92

0.69

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

287

1.21

0.68

2.3

2.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

319

1984

0.93

0.64

1.1

3.5

6.3

u/ml

0.50

548

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.65

0.64

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.65

0.64

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

200

1.24

0.64

1.3

16.7

17.1

nmol/l

0.06

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

248

0.79

0.64

1.0

0.2

1.7

u/ml

1.98

171

(3009677) Dengue virus Ab [Presence] in Serum

108

1.34

0.63

1.3

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.64

0.63

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

202

0.77

0.62

1.2

1.5

0.1

0.3

umol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

143

0.73

0.62

1.7

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

325

2015

0.93

0.61

1.1

1.5

3.3

u/ml

0.89

105

634

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

528

0.86

0.61

1.3

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.39

0.60

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

181

1.24

0.60

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

276

1.19

0.59

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

171

1.25

0.59

3.0

1.7

0.6

0.7

u/field

0.10

171

(40760512) CD34 cells/100 cells in Bone marrow

1.73

0.58

1.2

1.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

314

1.18

0.58

1.1

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

182

1.24

0.58

1.0

1.1

19.0

18.3

u/ml

0.04

151

(3003157) Bacteria [#/volume] in Mother's milk

0.64

0.57

3.3

7.1

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

1.57

0.57

2.1

3.5

262.4

391.0

nmol/l

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.57

0.57

1.0

0.2

0.1

u/ml

—

(40759632) Porphyrins [Mass/mass] in Stool

1.65

0.56

1.2

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

171

899

1.10

0.55

1.1

10.6

u/ml

1.60

560

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

311

0.84

0.54

1.3

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

286

1.17

0.51

1.0

1.1

0.1

0.6

u/ml

1.47

148

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

364

1980

1.06

0.51

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.62

0.50

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

451

0.87

0.50

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.59

0.47

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

355

0.86

0.46

1.0

21.0

19.8

mmol/l

1.59

335

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

191

1189

0.93

0.45

1.8

2.0

—

(4133840)

124

651

1.10

0.45

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.69

0.45

1.0

—

(40762814) Titanium [Mass/volume] in Blood

162

1.21

0.45

1.9

2.5

3.2

5.8

ug/l

1.38

(3036005) Urine sediment comments by Light microscopy Narrative

1.70

0.44

1.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.48

0.44

2.6

2.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.44

0.43

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

524

0.89

0.43

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

771

4611

0.96

0.43

1.1

4.3

4.8

u/ml

0.28

319

1869

(3023430) Cat dander IgE Ab [Units/volume] in Serum

725

4340

0.96

0.43

1.1

4.4

5.6

u/ml

0.94

316

1874

(40758292) HTLV I+II Ab panel - Serum

357

1.13

0.42

1.3

1.4

—

(3022670) pH of Venous cord blood

101

0.74

0.42

1.2

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

296

1808

0.94

0.42

1.0

1.1

0.5

0.9

u/ml

0.50

271

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

0.8

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

17.2

—

(3041184) Isoniazid [Presence] in Urine

1.52

0.41

2.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

228

1.17

0.41

2.2

2.5

3.6

mg/l

3.70

220

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.44

0.39

1.0

—

11332.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

138

0.79

0.39

1.7

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.33

0.38

1.2

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.30

0.37

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.51

0.37

1.2

1.1

728.3

2338.3

titre

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

212

0.84

0.37

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.44

0.36

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.28

0.35

1.1

1.0

0.1

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

195

1.15

0.33

1.1

33.0

32.3

u/ml

0.02

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

195

1.15

0.33

1.1

15.7

25.9

u/ml

—

(3018001) Oat IgE Ab [Units/volume] in Serum

206

1.15

0.33

1.0

0.1

1.1

u/ml

0.71

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

633

3771

0.97

0.32

1.0

1.1

0.8

0.4

u/ml

0.55

151

830

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.28

0.31

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

158

857

1.06

0.30

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

197

1.14

0.30

1.0

0.2

1.7

u/ml

1.39

145

(3049233) Organic acids panel - Urine

1.25

0.29

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1111

6285

1.02

0.27

1.1

1.8

1.7

u/ml

0.21

489

2695

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

375

0.91

0.27

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.28

0.27

4.7

5.9

0.2

mmol/l

0.35

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.74

0.25

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

136

0.85

0.25

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.37

0.24

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

151

919

0.95

0.24

1.0

13.4

9.8

u/ml

0.45

129

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.82

0.23

1.0

0.1

0.4

u/ml

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

169

1.13

0.23

1.2

1.1

1.3

2.7

u/ml

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.2

—

(40758358) Immune stain study

0.82

0.22

1.0

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

810.9

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(4038314)

297

0.91

0.21

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

115

0.85

0.20

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

2401

13716

1.01

0.20

2.8

2.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

350

1.07

0.18

1.1

0.4

3.9

u/ml

3.92

276

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1596

9307

0.99

0.14

1.5

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

685

4017

0.98

0.14

1.1

3.2

3.0

u/ml

0.18

315

2213

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

219

0.92

0.14

1.1

1.5

6.7

8.9

u/ml

0.17

182

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.81

0.14

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

327

1.06

0.13

1.0

1.1

0.3

2.2

u/ml

0.92

169

(3013762) Body weight Measured

1.13

0.13

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

949

5412

1.01

0.13

1.1

1.3

1.1

u/ml

0.37

409

2470

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1642

9394

1.01

0.13

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

218

0.93

0.13

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

232

1.07

0.13

1.1

1.0

0.2

1.1

u/ml

3.48

141

(3032641) Amino acids panel - Urine

1.18

0.12

1.6

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

2574

14763

1.01

0.12

2.8

2.1

—

(40768793) Breast Pathology biopsy report

763

4462

0.99

0.12

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

318

1.05

0.11

1.0

1.1

0.0

1.0

u/ml

1.88

162

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

28776

165983

1.00

0.11

3.6

3.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

139

1.08

0.10

1.0

0.1

10.5

u/ml

0.53

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

207

1.06

0.09

1.0

1.1

9.0

7.6

u/ml

0.16

141

(46235168) Fasting glucose [Moles/volume] in Blood

279

0.95

0.09

1.3

1.1

6.7

mmol/l

0.02

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

102

606

0.97

0.08

1.2

0.9

9.2

u/ml

3.82

438

(3003888) Timothy IgE Ab [Units/volume] in Serum

994

5697

1.01

0.08

1.1

5.8

u/ml

0.04

531

3126

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.04

0.07

1.1

1.3

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.89

0.07

1.0

1.3

23.1

28.8

mg/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

283

1656

0.99

0.07

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.85

0.06

1.4

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

663

3858

0.99

0.06

1.6

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.92

0.06

1.0

0.2

0.6

u/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

289

1652

1.01

0.05

1.2

1.4

1.5

g/l

0.25

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

163

928

1.01

0.04

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

571

0.98

0.04

1.1

1.3

2.3

9.2

u/ml

1.10

137

(1617658) Protocol used for examination of sentinel lymph nodes

244

1397

1.01

0.03

1.1

1.0

—

(3022475) Manganese [Moles/volume] in Blood

150

1.04

0.03

1.4

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.06

0.02

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

174

1.03

0.02

1.1

1.0

0.2

0.7

u/ml

1.03

162

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

243

1.02

0.02

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

945

5468

1.00

0.02

1.1

2.1

2.4

u/ml

0.31

246

1417

(3027944) Amphetamines [Presence] in Urine

2533

14634

1.00

0.01

2.7

2.0

—

(3028300) Cannabinoids [Presence] in Urine

2581

14896

1.00

0.00

2.8

2.1

—

(3027008) Opiates [Presence] in Urine

2574

14858

1.00

0.00

2.7

2.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.02

0.00

1.2

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

155

1.01

0.00

1.0

1.1

0.1

12.3

u/ml

0.52

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

440

1.00

0.00

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

357

1.00

0.00

1.0

1.1

1.0

6.1

u/ml

2.12

280

(3011325) HIV 1+2 Ab [Presence] in Serum

112

0.98

0.00

1.1

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

143

827

1.00

0.00

2.9

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.00

0.00

1.0

1.1

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.03

0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: FG_CVD – Cardiovascular diseases (excluding rheumatic etc)

GWS hits: 101

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cardiovascular diseases (excluding rheumatic etc)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints